ï¼»ï¼ï¼ãªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªã®æ¸¬å®æ¹æ³ï¼½

æ¬çºæã®ç¬¬ï¼ã®å®æ½æ æ§ã¯ãè¢«é¨è ããæ¡åãããçä½è©¦æä¸­ã®ãªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªãæ¸¬å®ããæ¹æ³ã«é¢ããã [1. Method for measuring phosphorylated tau protein]

A first embodiment of the present invention relates to a method for measuring phosphorylated tau protein in a biological sample collected from a subject.

ï¼»ï¼ï¼ï¼ï¼ç¨èªã®èª¬æï¼½

åãã«ãæ¬å®æ½æ æ§ã«ããã¦ä½¿ç¨ãããç¨èªã«ã¤ãã¦èª¬æãããæ¬å®æ½æ æ§ã«ããã¦ä½¿ç¨ãããç¨èªã®èª¬æã¯ãä»ã®å®æ½æ æ§ã®èª¬æã«ããã¦ãæ´ç¨ãããã [1-1. Explanation of terms]

First, the terms used in this embodiment will be described. The explanation of terms used in this embodiment is also incorporated in the description of other embodiments.

æ¬çºæã«ããã¦è¢«é¨è ã¯ãç¹ã«å¶éãããå¥å¸¸è åã¯èªç¥éå®³è¥ããã¯ä¸­æ¢ç¥çµç³»ã®å¤æ§ç¾æ£ãçãããªãè ã§ãã£ã¦ãããã¾ããèªç¥éå®³åã¯ä¸­æ¢ç¥çµç³»ã®å¤æ§ç¾æ£ãçãããè ã§ãã£ã¦ããããã¾ããä¸å®ã®å¹´é½¢å±¤ãä¾ãã°ï¼ï¼æ­³ä»¥ä¸ãï¼ï¼æ­³ä»¥ä¸ãï¼ï¼æ­³ä»¥ä¸ãï¼ï¼æ­³ä»¥ä¸ãï¼ï¼æ­³ä»¥ä¸ãåã¯ï¼ï¼æ­³ä»¥ä¸ã®è ãè¢«é¨è ã¨ãã¦ãããã In the present invention, the subject may be a healthy person or a person who is not suspected of having a cognitive disorder or a degenerative disease of the central nervous system without particular limitation. In addition, a person may be suspected of having a cognitive disorder or a degenerative disease of the central nervous system. Further, a certain age group, for example, a person aged 30 years or older, 40 years or older, 50 years or older, 60 years or older, 70 years or older, or 80 years or older may be a subject.

è¢«æ¤è ããæ¡åãããçä½è©¦æã¯ãªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªãå«ã¿å¾ãè©¦æã§ããã°ç¹ã«éå®ããããä¾ãã°é«æ¶²ãè¡æ¶²è©¦æãªã©ãæãããããè¡æ¶²è©¦æã«ã¯ãå ¨è¡ãè¡æ¼¿ãè¡æ¸ ç­ãå«ã¾ãããå¥½ã¾ããã¯è¡æ¼¿åã¯è¡æ¸ ã§ãããããå¥½ã¾ããã¯è¡æ¼¿ã§ãããè¡æ¼¿ã¯ããããªã³å¡©ï¼å¥½ã¾ããã¯ãããªã¦ã å¡©ï¼æ¡è¡ãã¯ã¨ã³é ¸å¡©ï¼å¥½ã¾ããã¯ãããªã¦ã å¡©ï¼æ¡è¡ãã¨ãã¬ã³ã¸ã¢ãã³åé ¢é ¸ï¼ï¼¥ï¼¤ï¼´ï¼¡ï¼å¡©ï¼å¥½ã¾ããã¯ãããªã¦ã å¡©åã¯ã«ãªã¦ã å¡©ï¼æ¡è¡ãããå ¨è¡ããåé¢ãããã¨ãã§ããããããå¥½ã¾ããã¯ãè¡æ¼¿ã¯ãï¼¥ï¼¤ï¼´ï¼¡å¡©æ¡è¡ãåã¯ãããªã³å¡©æ¡è¡ãããå ¨è¡ããåé¢ãããè¡æ¼¿ã§ããã The biological sample collected from the subject is not particularly limited as long as it is a sample that can contain phosphorylated tau protein, and examples thereof include cerebrospinal fluid and blood samples. Blood samples include whole blood, plasma, serum and the like. It is preferably plasma or serum, and more preferably plasma. Plasma can be separated from whole blood collected with heparin salt (preferably sodium salt), citrate (preferably sodium salt), and ethylenediamine tetraacetic acid (EDTA) salt (preferably sodium or potassium salt). can. More preferably, the plasma is plasma separated from whole blood collected by EDTA salt collection or heparin salt collection.

æ¬çºæã«ããã¦ãã¿ã¦ã¿ã³ãã¯è³ªã¯ãï¼°ï½ï½ï½ï½ ï½ ï½ï½ ï½ï½ï½ï½ï½ ï½ï½ï½ï½ï½ï½ ï½ï½ï¼ï½ï½ï½ã§ãããä¾ãã°ããç±æ¥ã®ãã®ã¯ãï¼µï½ï½ï¼°ï½ï½ï½ï¼«ï¼¢ï¼ï¼³ï½ï½ï½ï½ï¼ï¼°ï½ï½ï½ï¼ï¼°ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï½ï½ï½ï½ï½ï¼ï¼ï¼ï½ï½ï½ï¼ï½ï½ï½ï½ï¼ï½ï½ï½ï¼ï½ï½ï½ï¼ï½ï½ï½ï¼ï½ï½ï½ï½ï½ ï½ï½ï¼ï¼°ï¼ï¼ï¼ï¼ï¼ãï¼ï¼ï¼ï¼å¹´ï¼æï¼ï¼æ¥ç¾å¨ï¼ã§ç»é²ããã¦ããã¿ã³ãã¯è³ªãæãããã¨ãã§ããã In the present invention, the tau protein is Paired healthy-tau, for example, a human-derived protein is UniProtKB / Swiss-Prot: P10636.5 (https://www.ncbi.nlm.nih.gov/protein/P10636). , As of July 15, 2017).

ãªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªã¯ãã¿ã¦ã¿ã³ãã¯è³ªããªã³é ¸åããã¦ããéãå¶éãããªããä¾ãã°ããªã³é ¸åé¨ä½ã¨ãã¦ã¯ãåè¨ã¢ã¯ã»ãã·ã§ã³çªå·ã®ã¢ããé ¸é åã®ï¼ï¼ï¼çªç®ãï¼ï¼ï¼çªç®ãï¼ï¼ï¼çªç®ãï¼ï¼ï¼çªç®ãï¼ï¼ï¼çªç®ãï¼ï¼ï¼çªç®ãï¼ï¼ï¼çªç®ãï¼ï¼ï¼çªç®ãï¼ï¼ï¼çªç®ãï¼ï¼ï¼çªç®ãï¼ï¼ï¼çªç®ãï¼ï¼ï¼çªç®ãåã³ï¼ï¼ï¼çªç®ãããªãç¾¤ããé¸æãããå°ãªãã¨ãï¼ã¤ã®ã»ãªã³æ®åºãåã³ï¼åã¯ï¼ï¼ï¼çªç®ãï¼ï¼ï¼çªç®ãï¼ï¼ï¼çªç®ãï¼ï¼ï¼çªç®ãï¼ï¼ï¼çªç®ãåã³ï¼ï¼ï¼çªç®ãããªãç¾¤ããé¸æãããå°ãªãã¨ãï¼ã¤ã®ã¹ã¬ãªãã³æ®åºã§ãããå¥½ã¾ããã¯ãï¼ï¼ï¼çªç®ã®ã¹ã¬ãªãã³ãï¼ï¼ï¼çªç®ã®ã»ãªã³ãï¼ï¼ï¼çªç®ã®ã¹ã¬ãªãã³ãåã³ï¼ï¼ï¼çªç®ã®ã»ãªã³ãããªãç¾¤ããé¸æãããå°ãªãã¨ãï¼ã¤ã§ããã Phosphorylated tau protein is not limited as long as the tau protein is phosphorylated. For example, as the phosphorylation site, the amino acid sequence of the accession number is 199th, 202nd, 214th, 262nd, 356th, 396th, 404th, 409th, 416th, 422th, 516th, 516th. At least one serine residue selected from the group consisting of th and 717th, and / or at least one selected from the group consisting of 181st, 205th, 212th, 217th, 231st, and 534th. It is a threonine residue. Preferably, it is at least one selected from the group consisting of threonine at position 181, serine at position 199, threonine at position 231 and serine at position 262.

æ¬çºæã«ããã¦ãæä½ã¯ãã¿ã¦ã¿ã³ãã¯è³ªåã³ï¼åã¯ãªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªãèªè­ã§ããéãå¶éãããªãããªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªãèªè­ããæä½ã¯ãå¥½ã¾ããã¯ãªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªã«ç¹ç°çã«çµåããæä½ï¼ãªã³é ¸åããã¦ããªãã¿ã¦ã¿ã³ãã¯è³ªã¨ã¯çµåããªãããªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªç¹ç°æä½ï¼ã§ããããªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªç¹ç°æä½ï¼ä»¥ä¸ããï½ï¼ï½ï½ï½ç¹ç°æä½ãã¨ãããï¼ã¯ãã¿ã¦ã¿ã³ãã¯è³ªã®ãªã³é ¸åããããªã³é ¸åé¨ä½ãèªè­ãã¦ããããããªã³é ¸åã«ä¼´ã£ã¦æ§é ãå¤åããã¿ã¦ã¿ã³ãã¯è³ªãèªè­ãã¦ããããããå¥½ã¾ããã¯ãï½ï¼ï½ï½ï½ç¹ç°æä½ã¯ãã¿ã¦ã¿ã³ãã¯è³ªã®ãªã³é ¸åããããªã³é ¸åé¨ä½ãèªè­ããã In the present invention, the antibody is not limited as long as it can recognize tau protein and / or phosphorylated tau protein. The antibody that recognizes phosphorylated tau protein is preferably an antibody that specifically binds to phosphorylated tau protein (a phosphorylated tau protein-specific antibody that does not bind to non-phosphorylated tau protein). Phosphorylated tau protein-specific antibody (hereinafter, also referred to as "p-tau-specific antibody") may recognize the phosphorylated phosphorylation site of tau protein, but the structure of tau protein has changed with phosphorylation. May be recognized. More preferably, the p-tau-specific antibody recognizes the phosphorylated phosphorylation site of tau protein.

æä½ã¨ãã¦ã¯ãã¿ã¦ã¿ã³ãã¯è³ªããªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªãåã¯ãããã®ä¸é¨ãæåã¨ãã¦ããä»¥å¤ã®åç©ã«å ç«ãã¦å¾ãããããªã¯ã­ã¼ãã«æä½ãã¢ãã¯ã­ã¼ãã«æä½ãåã³ãããã®æ­çï¼ä¾ãã°ãï¼¦ï½ï½ãï¼¦ï¼ï½ï½ï¼ï¼ç­ï¼ã®ããããç¨ãããã¨ãã§ãããã¾ããå ç«ã°ã­ããªã³ã®ã¯ã©ã¹åã³ãµãã¯ã©ã¹ã¯ç¹ã«å¶éãããªããã¾ãããã¡ã¼ã¸ãã£ã¹ãã¬ã¤æ³ç­ã«ããæä½ã©ã¤ãã©ãªããé¸æããããã®ãä½¿ç¨ãã¦ãããã Antibodies include tau protein, phosphorylated tau protein, or polyclonal antibodies obtained by immunizing animals other than humans using a part of them as an antigen, monoclonal antibodies, and fragments thereof (for example, Fab, F (ab)). Any of 2 etc.) can be used. Further, the class and subclass of immunoglobulin are not particularly limited. Further, those selected from the antibody library by the phage display method or the like may be used.

ããã«ãæä½ã¯å¸è²©ã®ãã®ãä½¿ç¨ãã¦ããããã¿ã¦ã¿ã³ãã¯è³ªãèªè­ããæä½ã¨ãã¦ã¯ãä¾ãã°ãï¼´ï½ï½ ï½ï½ï½ ï¼¦ï½ï½ï½ï½ ï½ ï¼³ï¼©ï¼¥ï¼®ï¼´ï¼©ï¼¦ï¼©ï¼£ç¤¾ã®ï¼´ï½ï½ ï¼­ï½ï½ï½ï½ï½ï½ï½ï½ï½ ï¼¡ï½ï½ï½ï½ï½ï½ï½ï¼ï½ï½ï½ï½ï½ ï¼ï¼¨ï¼´ï¼ãï¼´ï¼ï¼ãï¼´ï¼¡ï¼µï¼ï¼ï¼ç­ãä½¿ç¨ãããã¨ãã§ãããã¾ãããªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªãèªè­ããæä½ã¨ãã¦ã¯ãä¾ãã°ãï¼´ï½ï½ ï½ï½ï½ ï¼¦ï½ï½ï½ï½ ï½ ï¼³ï¼©ï¼¥ï¼®ï¼´ï¼©ï¼¦ï¼©ï¼£ç¤¾ã®ï¼°ï½ï½ï½ï½ï½ï½ï¼ï¼´ï½ï½ï¼ï¼´ï½ï½ï¼ï¼ï¼ï¼ ï¼¡ï½ï½ï½ï½ï½ï½ï½ï¼ï½ï½ï½ï½ï½ ï¼ï¼ï¼¨ï¼£ï¼¬ï¼£ï¼ãï¼°ï½ï½ï½ï½ï½ï½ï¼ï¼´ï½ï½ ï¼ï¼´ï½ï½ï¼ï¼ï¼ï¼ ï¼°ï½ï½ï½ï½ï½ï½ï½ï½ï½ ï¼¡ï½ï½ï½ï½ï½ï½ï½ï¼ï¼£ï½ï½ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ãï¼°ï½ï½ï½ï½ï½ï½ï¼ï¼´ï½ï½ï¼ï¼³ï½ ï½ï¼ï¼ï¼ï¼ ï¼°ï½ï½ï½ï½ï½ï½ï½ï½ï½ ï¼¡ï½ï½ï½ï½ï½ï½ï½ï¼ï¼£ï½ï½ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼§ï¼ç­ãä½¿ç¨ãããã¨ãã§ããã Further, a commercially available antibody may be used. As an antibody that recognizes tau protein, for example, Tau Monoclonal Antibodies (clone: HT7, T46, TAU-5) manufactured by Thermo Fisher SIENTIFIC can be used. Examples of the antibody that recognizes the phosphorylated tau protein include Phospho-Tau (Thr181) Antibody (clone: 5HCLC), Phospho-Tau (Thr231) PolyclonalAnti, Ph. Tau (Ser214) Polyclonal Antibody (Cat #: 44-742G) and the like can be used.

æ¬æç´°æ¸ã«ããã¦ãæææä½ã¨ã¯ããªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªã¨çµåããä¸ã¤å¾è¿°ã®ãã¼ãºä¸ã«åºå®ãããæä½ã§ããããã¼ãºã¸ã®åºå®ã¯ãã¢ãã¸ã³ï¼åã¯ã¹ãã¬ããã¢ãã¸ã³ï¼åã³ããªãã³ãªã©ã®ç©è³ªãä»å¨ããéæ¥çãªåºå®ã§ãã£ã¦ãããã As used herein, a capture antibody is an antibody that binds to phosphorylated tau protein and is immobilized on beads described below. Fixation to the beads may be indirect fixation mediated by substances such as avidin (or streptavidin) and biotin.

æ¬æç´°æ¸ã«ããã¦ãæ¤åºæä½ã¨ã¯ããªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªã¨çµåããå¥½ã¾ããã¯å¾è¿°ã®æ¨è­ç©è³ªãåããæä½ã§ããã As used herein, the detection antibody is an antibody that binds to a phosphorylated tau protein and preferably comprises a labeling substance described below.

æææä½åã³æ¤åºæä½ã®å°ãªãã¨ãä¸æ¹ã¯ãï½ï¼ï½ï½ï½ç¹ç°æä½ã§ãããããã«ãããçä½è©¦æä¸­ã®ã¿ã¦ã¿ã³ãã¯è³ªã®ãã¡ããªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªãç¹ç°çã«æ¤åºãããã¨ãã§ããã At least one of the capture antibody and the detection antibody is a p-tau specific antibody. This makes it possible to specifically detect the phosphorylated tau protein among the tau proteins in the biological sample.

æææä½åã³æ¤åºæä½ã®ããããï½ï¼ï½ï½ï½ç¹ç°æä½ãç¨ããå ´åããããã®æä½ã®ã¨ããã¼ããç°ãªããã¨ãå¥½ã¾ããã When p-tau-specific antibodies are used for both the capture antibody and the detection antibody, it is preferable that the epitopes of these antibodies are different.

æææä½åã³æ¤åºæä½ã®ä¸æ¹ã«ï½ï¼ï½ï½ï½ç¹ç°æä½ãç¨ããå ´åãä»æ¹ã®æä½ã¯ãªã³é ¸åã®æç¡ã«ãããããã¿ã¦ã¿ã³ãã¯è³ªã¨çµåå¯è½ãªæä½ã§ãããã¨ãå¥½ã¾ããã When a p-tau-specific antibody is used for one of the capture antibody and the detection antibody, it is preferable that the other antibody is an antibody capable of binding to tau protein regardless of the presence or absence of phosphorylation.

æ¬çºæã«ããã¦ãã¼ãºã¯ãåã ã®ãã¼ãºãç©ºéçã«åé¢ãããã¨ãã§ããç¹æ§ãæããéãå¶éãããªããåè¨ãã¼ãºã¯ãè¤æ°ã®å ´æï¼ä¾ãã°ã¦ã§ã«ï¼ã«ç©ºéçã«åé¢ãããã¨ãã§ãããããªå½¢æ ã§æä¾ããã¦ããããä¾ãã°ããã¼ãºã¯ãçå½¢ããã£ã¹ã¯ããªã³ã°ãç«æ¹ä½ç¶ç­ã®å½¢ç¶ã¨ãããã¨ãã§ãããã¾ããåè¨ãã¼ãºã¯ãå¾®ç²å­ï¼ä¾ãã°ãæ¶²ä½ä¸­ã«æ¸æ¿ãããè¤æ°ã®ç²å­ï¼ããããã¥ã¼ãç­ã§ãã£ã¦ãããã In the present invention, the beads are not limited as long as they have the property of being able to spatially separate individual beads. The beads may be provided in a form that can be spatially separated into multiple locations (eg, wells). For example, the beads can be in the shape of a sphere, disc, ring, cube, or the like. Further, the beads may be fine particles (for example, a plurality of particles suspended in a liquid), nanotubes, or the like.

ãã¼ãºã®ãµã¤ãºåã¯å½¢ç¶ã¯ãé©å®è¨­è¨ãããã¨ãã§ãããä¾ãã°ããã¼ãºã®å½¢ç¶ã«ã¯ãçä½ãç«æ¹ä½ãæ¥åä½ããã¥ã¼ãç­ãå«ã¾ããããã¼ãºã®å¹³åç´å¾ï¼å®è³ªçã«çå½¢ã®å ´åï¼ãåã¯å¹³åæå¤§æ­é¢å¯¸æ³ï¼ä»ã®å½¢ç¶ã®å ´åï¼ã¯ãç´ï¼ï¼ï¼Î¼ï½ããå¤§ãããç´ï¼Î¼ï½ããå¤§ãããç´ï¼ï¼Î¼ï½ããå¤§ããç´ï¼ï¼ï¼Î¼ï½ããå¤§ãããç´ï¼ï½ï½ããå¤§ãããåã¯åæ§ã®ãã®ãå«ããã¾ããã¼ãºã®å¹³åç´å¾åã¯ãã¼ãºã®æå¤§å¤å¯¸ã¯ãç´ï¼ï¼ï¼Î¼ï½ããç´ï¼ï¼ï¼Î¼ï½ãç´ï¼Î¼ï½ããç´ï¼ï¼ï¼Î¼ï½ãç´ï¼ï¼Î¼ï½ããç´ï¼ï¼ï¼Î¼ï½ç´ï¼ï¼ï¼Î¼ï½ããç´ï¼ï½ï½ã®éãç´ï¼Î¼ï½ããç´ï¼ï¼ï½ï½ã®éãç´ï¼ï¼ï¼Î¼ï½ããç´ï¼ï¼Î¼ï½ã®éç­ã§ãããæ¬å®æ½æ æ§ã«ããã¦ä½¿ç¨ãããã¼ãºã®å¹³åç´å¾åã¯å¹³åæå¤§æ­é¢å¯¸æ³ã¯ããã¼ãºã®ç´å¾ï¼æå¤§æ­é¢å¯¸æ³ã®ç®è¡å¹³åå¤ã§ããã The size or shape of the beads can be appropriately designed. For example, the shape of the beads includes a sphere, a cube, an ellipsoid, a tube, and the like. The average diameter of the beads (in the case of a substantially spherical shape), or the average maximum cross-sectional dimension (in the case of other shapes), is greater than about 0.1 Î¼m, greater than about 1 Î¼m, greater than about 10 Î¼m and greater than about 100 Î¼m, about 1 mm. Includes larger or similar. The average diameter of the beads or the maximum outer size of the beads is about 0.1 Î¼m to about 100 Î¼m, about 1 Î¼m to about 100 Î¼m, about 10 Î¼m to about 100 Î¼m, between about 0.1 Î¼m and about 1 mm, and between about 1 Î¼m and about 10 mm. It is between about 0.1 Î¼m and about 10 Î¼m. The average diameter or average maximum cross-sectional dimension of the beads used in this embodiment is an arithmetic mean value of the bead diameter / maximum cross-sectional dimension.

ãã¼ãºã®å¹³åæå¤§æ­é¢å¯¸æ³ã¯ãä¾ãã°ã¬ã¼ã¶ã¼å æ£ä¹±ãé¡å¾®é¡æ³ããµããåæãé»æ°æµææ¹å¼ãåã¯ä»ã®å ¬ç¥ã®æè¡ãä½¿ç¨ãã¦æ¸¬å®ãããã¨ãã§ããããã¼ãºã®å¹³åç´å¾ã¯ãã¬ã¼ã¶ã¼åæã»æ£ä¹±æ³ã«ããç²åº¦åå¸æ¸¬å®è£ ç½®ã«ããæ¸¬å®ãããä½ç©åºæºã®ã¡ã¸ã¢ã³å¾ã§ããããã®ãããªç²åº¦åå¸æ¸¬å®è£ ç½®ã¨ãã¦ã¯ãæ¥æ©è£ æ ªå¼ä¼ç¤¾è£½ããã¤ã¯ã­ãã©ãã¯ï¼­ï¼´ï¼ï¼ï¼ï¼ï¼©ï¼©ãç­ãæããããã The average maximum cross-sectional dimension of the beads can be measured using, for example, laser light scattering, microscopy, sieving analysis, electrical resistance schemes, or other known techniques. The average diameter of the beads is a volume-based median diameter measured by a particle size distribution measuring device by a laser diffraction / scattering method. Examples of such a particle size distribution measuring device include "Microtrack MT3000II" manufactured by Nikkiso Co., Ltd.

ã¾ããã¼ãºã¯ãæ¸¬å®ã«ããã¦ä½¿ç¨ãããæº¶åªåã¯æº¶æ¶²ã«ä¸æº¶æ§åã¯å®è³ªçã«ä¸æº¶æ§ã§ããããã¼ãºã¯ãå¤å­è³ªåã¯å®è³ªçã«å¤å­è³ªãä¸­ç©ºãé¨åçã«ä¸­ç©ºç­ã§ãã£ã¦ãããããéå¤å­è³ªåºä½åã¯å®è³ªçã«éå¤å­è³ªã®åºä½ï¼ä¾ãã°ãæ¬è³ªçã«å­ããªãï¼ã§ãããã¨ãå¥½ã¾ããããã¼ãºã¯ãæº¶åªããå®è³ªçã«å¸ååã¯å¸åãããã®ã§ãã£ã¦ãããããå¥½ã¾ããã¯éå¸åãå®è³ªçã«éå¸åã§ããã The beads are also insoluble or substantially insoluble in the solvent or solution used in the measurement. The beads may be porous or substantially porous, hollow, partially hollow, etc., but may be a non-porous solid or a substantially non-porous solid (eg, essentially no pores). It is preferable to have. The beads may be those that substantially absorb or absorb the solvent, but are preferably non-absorbent and substantially non-absorbent.

ããã«ããã¼ãºã®ææã¯ããã©ã¹ããã¯åã¯åæããªãã¼ï¼ä¾ãã°ãããªã¨ãã¬ã³ãããªãã­ãã¬ã³ãããªã¹ãã¬ã³ãããªã¢ãããããªã¦ã¬ã¿ã³ããã§ãã¼ã«ããªãã¼åã¯ããã­ã»ã«ã­ã¼ã¹ç­ï¼ãå¤©ç¶ç±æ¥ããªãã¼ï¼ã©ããã¯ã¹ã´ã ãå¤ç³é¡éå±ãåã¯éå±ååç©ï¼ä¾ãã°ãéãéãã¹ãã¼ã«ãã¢ã«ããã¦ã ãé ç­ãå«ãï¼ãç¡æ©ã¬ã©ã¹ãã·ãªã«ãåã³ãããã®æ··åç©ç­ãé¸æãããã¨ãã§ãããåè¨ãã¼ãºã¯ãç£æ§ææãå«ããã¨ãå¥½ã¾ãããããã«ãåè¨ãã¼ãºã¯ãå å­¦çã«æ¤åºã§ãããã¨ãå¥½ã¾ããã In addition, the bead material may be a plastic or synthetic polymer (eg polyethylene, polypropylene, polystyrene, polyamide, polyurethane, phenol polymer or nitrocellulose), a naturally occurring polymer (latex rubber, polysaccharide metal, or metal compound (eg gold). , Silver, steel, aluminum, copper and the like), inorganic glass, silica, and mixtures thereof and the like can be selected. The beads preferably contain a magnetic material. Further, the beads are optically. It is preferable that it can be detected.

åè¨ãã¼ãºã¯ãå¸è²©ã®ãã®ãä½¿ç¨ãããã¨ãã§ãããä¾ãã°ãï¼¡ï½ï½ï½ï½ ï½ï½ ï¼´ï½ ï½ï½ï½ï½ï½ï½ï½ï½ï½ ï½ç¤¾ã®ã«ã«ãã­ã·ã«å®è½åå¸¸ç£æ§ãã¼ãºï¼ç´å¾ï¼ï¼ï¼Î¼ï½ï¼ãä½¿ç¨ãããã¨ãã§ããã Commercially available beads can be used. For example, carboxyl-functionalized paramagnetic beads (diameter 2.7 Î¼m) from Agilent Technologies can be used.

æ¬çºæã«ããã¦ãææãã¼ãºã¯ãã¿ã¦ã¿ã³ãã¯è³ªåã³ï¼åã¯ãªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªï¼ä»¥ä¸ããæ¨çã¿ã³ãã¯è³ªãã¨ãããï¼ãå«ãè¤åä½ãåºå®åã§ãããã¼ãºã§ãããä¾ãã°ãä¸è¿°ã®ãã¼ãºã«æ¨çã¿ã³ãã¯è³ªã¨çµåã§ããåå­ï¼ä»¥ä¸ããææåå­ãã¨ãããï¼ãç´æ¥çåã¯éæ¥çã«åºå®ãããã®ãææãã¼ãºã¨ãããã¨ãã§ãããææåå­ã¨ãã¦ã¯ãä¸è¿°ã®æææä½ãä¾ç¤ºãããã In the present invention, the capture beads are beads capable of immobilizing a complex containing tau protein and / or phosphorylated tau protein (hereinafter, also referred to as âtarget proteinâ). For example, a molecule in which a molecule capable of binding to a target protein (hereinafter, also referred to as âcapture moleculeâ) is directly or indirectly fixed to the above-mentioned beads can be used as a capture bead. Examples of the capture molecule include the above-mentioned capture antibody.

ææãã¼ãºã®èª¿è£½æ¹æ³ã¯ããã¼ãºã«ææåå­ãçµåã§ããéãå¶éãããªããä¾ãã°ãææåå­ãæä½ã§ããå ´åã«ã¯ãç¹è¨±æç®ï¼ã«è¨è¼ã®æ¹æ³ã«ããèª¿è£½ãããã¨ãã§ãããã¾ããï¼±ï½ï½ï½ï½ï½ ï½ï½ï½ç¤¾ã®ï¼³ï½ï½ï½ï½ï¼´ï¼­ ï¼¨ï½ï½ï½ ï½ï½ï½ ï½ ï¼¡ï½ï½ï½ï½ ï¼¤ï½ ï½ï½ ï½ï½ï½ï½ï½ ï½ï½ ï½ï½ï½ç­ã®å¸è²©ã­ãããä½¿ç¨ãã¦ãææãã¼ãºãèª¿è£½ãã¦ããããææãã¼ãºã¯ãéç¹ç°ççµåãæå¶ãããããã¦ã·è¡æ¸ ã¢ã«ããã³ï¼ï¼¢ï¼³ï¼¡ï¼ãªã©ã§ãã­ãã­ã³ã°ããã¦ãã¦ãããã The method of preparing the capture beads is not limited as long as the capture molecule can be bound to the beads. For example, when the capture molecule is an antibody, it can be prepared by the method described in Patent Document 1. Capturing beads may also be prepared using a commercially available kit such as Quantlix's Simoa TM Homebrew Assay Development kit. The captive beads may be blocked with bovine serum albumin (BSA) or the like in order to suppress non-specific binding.

éææãã¼ãºã¯ãä¸è¨æ¨çã¿ã³ãã¯è³ªã¨å®è³ªçã«çµåããªããã¼ãºã§ãããéææãã¼ãºã¯ãææåå­ãåãã¦ããªããéææãã¼ãºã«ä½¿ç¨ããããã¼ãºã®æè³ªã¯ãææãã¼ãºã«ä½¿ç¨ããããã¼ãºã¨åããã®ã§ãã£ã¦ãããããç°ãªããã®ã§ãã£ã¦ããããã¾ããéææãã¼ãºã¨ãã¦ã¯ãä¾ãã°ãï¼±ï½ï½ï½ï½ï½ ï½ï½ï½ç¤¾ã®ï¼¤ï½ï½ ï¼ï¼¥ï½ï½ï½ï½ï½ ï½ ï¼¨ï½ ï½ï½ï½ ï½ ï¼¢ï½ ï½ï½ï½ãä½¿ç¨ãã¦ããããéææãã¼ãºã¯ãéç¹ç°ççµåãæå¶ãããããï¼¢ï¼³ï¼¡ãªã©ã§ãã­ãã­ã³ã°ããã¦ãã¦ãããã Non-capture beads are beads that do not substantially bind to the target protein. Non-capture beads do not have capture molecules. The material of the beads used for the non-capture beads may be the same as that of the beads used for the capture beads, but may be different. Further, as the non-capture beads, for example, Dye-Encoded Helper Beads manufactured by Quantlix may be used. The non-capture beads may be blocked by BSA or the like in order to suppress non-specific binding.

ï¼»ï¼ï¼ï¼ï¼æ¸¬å®æ¹æ³ï¼½

æ¬¡ã«ãæ¬å®æ½æ æ§ã®æ¸¬å®æ¹æ³ã«ã¤ãã¦èª¬æããã

æ¬å®æ½æ æ§ã¯ããªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªãå«ããµã³ãã¤ããå ç«è¤åä½ãå½¢æãããªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªãæ¤åºãããµã³ãã¤ããã¤ã ãã¢ãã»ã¤æ¹æ³ã§ãããæ¬å®æ½æ æ§ã¯ãéææãã¼ãºã®å­å¨ä¸ã§ãææãã¼ãºä¸ã«ãåè¨è¢«é¨è ããæ¡åããçä½è©¦æä¸­ã®æ¨çã¿ã³ãã¯è³ªã§ãããªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªã¨ãæææä½ã¨ãæ¤åºæä½ã¨ã®å ç«è¤åä½ãå½¢æããã¦ãåè¨éææãã¼ãºã¨åè¨å ç«è¤åä½ãçµåããææãã¼ãºã¨ãå«ãæ¸¬å®è©¦æãèª¿è£½ããå·¥ç¨ã¨ãåè¨æ¸¬å®è©¦æä¸­ã®å ç«è¤åä½ã«ç±æ¥ããã·ã°ãã«ãæ¤åºããå·¥ç¨ã¨ãå«ãã [1-2. Measuring method]

Next, the measuring method of this embodiment will be described.

This embodiment is a sandwich immunoassay method for forming a sandwich immune complex containing phosphorylated tau protein and detecting phosphorylated tau protein. In this embodiment, in the presence of non-capture beads, an immune complex of phosphorylated tau protein, which is a target protein in a biological sample collected from the subject, a capture antibody, and a detection antibody is formed on the capture beads. This includes a step of preparing a measurement sample containing the non-captured beads and the captured beads to which the immune complex is bound, and a step of detecting a signal derived from the immune complex in the measurement sample.

æ¬å®æ½æ æ§ã«ããã¦ãææãã¼ãºä¸ã«ãçä½è©¦æä¸­ã®æ¨çã¿ã³ãã¯è³ªã¨ãæææä½ã¨ãæ¤åºæä½ã¨ã®å ç«è¤åä½ãå½¢æãããæ¹æ³ã¯ãæ¬å®æ½æ æ§ãå®ç¾ã§ããéãå¶éãããªããæææä½ã¨ãæ¤åºæä½ã¨ã¯ãæ¨çã¿ã³ãã¯è³ªã®ç°ãªãã¨ããã¼ããèªè­ãããã¨ãå¥½ã¾ãããä¾ãã°ãææãã¼ãºä¸ã®ææåå­ã¨ãã¦ãã¿ã¦ã¿ã³ãã¯è³ªãèªè­ããæææä½ãç¨ããåãã«æææä½ã«çä½è©¦æä¸­ã®æ¨çã¿ã³ãã¯è³ªãçµåããã¦ãæ¨çã¿ã³ãã¯è³ªãææãã¼ãºä¸ã«çµåãããï¼å¥½ã¾ããã¯ãææããï¼ãæ¬¡ã«ããªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªãèªè­ããæ¤åºæä½ããæææä½ã«ææãããæ¨çã¿ã³ãã¯è³ªã«å«ã¾ãããªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªã«çµåããã¦å ç«è¤åä½ãå½¢æãããããããã¯ãä¾ãã°ãææãã¼ãºä¸ã®ææåå­ã¨ãã¦ããªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªãèªè­ããæææä½ãç¨ããåãã«æææä½ã«çä½è©¦æä¸­ã®æ¨çã¿ã³ãã¯è³ªãçµåããã¦ãæ¨çã¿ã³ãã¯è³ªãææãã¼ãºä¸ã«çµåãããï¼å¥½ã¾ããã¯ãææããï¼ãæ¬¡ã«ãã¿ã¦ã¿ã³ãã¯è³ªãèªè­ããæ¤åºæä½ããæææä½ã«ææããããªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªã«çµåããã¦å ç«è¤åä½ãå½¢æããããçä½è©¦æã¯ãä¾ãã°ï¼ï¼ï¼ï¼ï¼ ï¼ï½ï¼ï½ï¼ããï¼ï¼ï¼ï¼ï¼ ã®ããªã¨ãã¬ã³ã°ãªã³ã¼ã«ã½ã«ãã¿ã³ã¢ãã©ã¦ã©ã¼ãï¼ï¼´ï½ï½ ï½ ï½ï¼ç»é²åæ¨ï¼ï¼ï¼ï¼ï¼ç­ãå«ãï¼ããï¼Ãï¼°ï¼¢ï¼³ç­ã§å¸éãã¦ç¨ãã¦ãããã In the present embodiment, the method for forming an immune complex of the target protein in the biological sample, the capture antibody, and the detection antibody on the capture beads is not limited as long as the present embodiment can be realized. It is preferable that the capture antibody and the detection antibody recognize different epitopes of the target protein. For example, a capture antibody that recognizes tau protein is used as a capture molecule on the capture beads, and the capture antibody is first bound to the target protein in a biological sample to bind the target protein onto the capture beads (preferably, capture). do). Next, the detection antibody that recognizes the phosphorylated tau protein is bound to the phosphorylated tau protein contained in the target protein captured by the capture antibody to form an immune complex. Alternatively, for example, a capture antibody that recognizes phosphorylated tau protein is used as a capture molecule on the capture beads, and the target protein in the biological sample is first bound to the capture antibody to bind the target protein onto the capture beads ( Preferably to capture). Next, the detection antibody that recognizes tau protein is bound to the phosphorylated tau protein captured by the capture antibody to form an immune complex. The biological sample is diluted with 1 to 5 Ã PBS or the like containing, for example, 0.05% (v / v) to 0.15% polyethylene glycol sorbitan monolaurate (TweenÂ®-20) or the like. May be good.

ã¾ãå¥ã®æ æ§ã¨ãã¦ãçä½è©¦æä¸­ã®ãªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªã¨ãæææä½ã¨ãæ¤åºæä½ã¨ã®å ç«è¤åä½ãç·©è¡æ¶²ä¸­ã§å½¢æããã¦ãããææãã¼ãºã«çµåããã¦ãããããã¨ãã°ãã¢ãã¸ã³åã¯ã¹ãã¬ããã¢ãã¸ã³ãåºå®åãããã¼ãºã¨ãããªãã³æ¨è­ããæææä½ããªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªåã³æ¤åºæä½ã®è¤åä½ã¨ãæ¥è§¦ããããã¨ã«ãããå ç«è¤åä½ãè£è¶³ãã¼ãºä¸ã«åºå®ãããã¨ãã§ããã As another embodiment, an immune complex of the phosphorylated tau protein in the biological sample, the capture antibody, and the detection antibody may be formed in a buffer solution and then bound to the capture beads. For example, the immune complex can be immobilized on supplemental beads by contacting avidin or streptavidin-immobilized beads with a complex of biotin-labeled capture antibody, phosphorylated tau protein and detection antibody.

åè¨å ç«è¤åä½ã¯ãéææãã¼ãºã®å­å¨ä¸ã§å½¢æããããæ¸¬å®è©¦æãèª¿è£½ããéã®ææãã¼ãºã¨éææãã¼ãºã®åæ°æ¯ã¯ãææãã¼ãºãï¼ã¨ããã¨ãã«ãç´ï¼ï¼ï¼ä»¥ä¸ã§ãããå¥½ã¾ããã¯éææãã¼ãºãç´ï¼ï¼ï¼ããç´ï¼ã®ç¯å²ãããå¥½ã¾ããã¯ç´ï¼ããç´ï¼ã®ç¯å²ãæãå¥½ã¾ããã¯ï¼åå¾ã«èª¿æ´ãããã¨ãã§ãããå¥ã®æ æ§ã«ããã¦ã¯ãæ¸¬å®è©¦æãèª¿è£½ããéã®ææãã¼ãºã¨éææãã¼ãºã®åæ°æ¯ã¯ãææãã¼ãºãï¼ã¨ããã¨ãã«ãéææãã¼ãºãï¼ï¼ï¼ä»¥ä¸ã§ãããå¥½ã¾ããã¯éææãã¼ãºãï¼ï¼ï¼ããï¼ã®ç¯å²ãããå¥½ã¾ããã¯ï¼ããï¼ã®ç¯å²ãæãå¥½ã¾ããã¯ï¼ã§ãããçä½è©¦æåã¯å¸éããçä½è©¦æã¨æ··åããããã¼ãºå ¨ä½ã®æ°ã¯ãä¾ãã°ãçä½è©¦æåã¯å¸éããçä½è©¦æï¼ï¼ï¼Î¼ï½ã«å¯¾ãã¦ãï¼ï¼ï¼ï¼ï¼ï¼ï¼åããï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼åç¨åº¦ãå¥½ã¾ããã¯ãï¼ï¼ï¼ï¼ï¼ï¼ï¼åããï¼ï¼ï¼ï¼ï¼ï¼ï¼åç¨åº¦ã¨ãããã¨ãã§ããã The immune complex is formed in the presence of non-capturing beads. The number ratio of captured beads to non-captured beads when preparing a measurement sample is about 1.5 or more when the captured beads are 1, preferably in the range of about 1.5 to about 9 for non-captured beads. , More preferably in the range of about 4 to about 9, most preferably around 4. In another embodiment, the number ratio of the captured beads to the non-captured beads when preparing the measurement sample is 1.5 or more for the non-captured beads when the captured beads are 1, preferably the non-captured beads. The range is 1.5 to 9, more preferably 4 to 9, and most preferably 4. The total number of beads mixed with the biological sample or the diluted biological sample is, for example, about 100,000 to 1,000,000, preferably 400,000, per 100 Î¼l of the biological sample or the diluted biological sample. The number can be about 800,000 to 800,000.

æ¸¬å®è©¦æã®èª¿è£½ã¯ãå ç«è¤åä½ãå½¢æå¯è½ãªç·©è¡æ¶²ï¼ä¾ãã°ï¼ããï¼Ãï¼°ï¼¢ï¼³ï¼ä¸­ã§è¡ããã¨ãã§ãããåè¨ç·©è¡æ¶²ã¯ãï¼ï¼ï¼ï¼ï¼ ï¼ï½ï¼ï½ï¼ããï¼ï¼ï¼ï¼ï¼ ï¼ï½ï¼ï½ï¼ç¨åº¦ã®ï¼´ï½ï½ ï½ ï½ï¼ç»é²åæ¨ï¼ï¼ï¼ï¼ç­ã®çé¢æ´»æ§å¤ãå«ãã§ãã¦ããããã¾ããæ¸¬å®è©¦æã®èª¿è£½ä¸­ã«ãæææä½ã§çä½è©¦æä¸­ã®ãªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªãææããå¾ãæ¤åºæä½ãçµåãããåã«ãææãã¼ãºãåè¨ç·©è¡æ¶²ã§æ´æµãã¦ããããã¾ããææãã¼ãºä¸ã«ãçä½è©¦æä¸­ã®ãªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªã¨ãæ¤åºæä½ã¨ãæææä½ã¨ã®å ç«è¤åä½ãå½¢æãããå¾ã«ããææãã¼ãºãåè¨ç·©è¡æ¶²ã§æ´æµãã¦ãããã Preparation of the measurement sample can be carried out in a buffer solution (for example, 1 to 5 Ã PBS) in which an immune complex can be formed. The buffer solution may contain a surfactant such as TweenÂ®-20 in an amount of about 0.05% (v / v) to 0.15% (v / v). Further, during the preparation of the measurement sample, the capture beads may be washed with the buffer solution after capturing the phosphorylated tau protein in the biological sample with the capture antibody and before binding the detection antibody. Further, the capture beads may be washed with the buffer solution even after an immune complex of the phosphorylated tau protein in the biological sample, the detection antibody, and the capture antibody is formed on the capture beads.

æ¤åºæä½ã¯ãåè¨çä½è©¦æåã¯å¸éããçä½è©¦æï¼ï¼ï¼Î¼ï½ã«å¯¾ãã¦ãçµæ¿åº¦ã§ï¼ï¼ï¼ï¼Î¼ï½ï¼ï½ï½ããï¼Î¼ï½ï¼ï½ï½ãï¼ï¼ï¼Î¼ï½ï¼ï½ï½ããï¼ï¼ï¼Î¼ï½ï¼ï½ï½ç¨åº¦ã¨ãªãããã«æ·»å ãããã¨ãã§ãããæ¤åºæä½ã¯ãæ¨è­ç©è³ªãåãããã¨ãå¥½ã¾ããã The detection antibody may be added to 100 Î¼l of the biological sample or diluted biological sample at a final concentration of about 0.05 Î¼g / ml to 1 Î¼g / ml and 0.1 Î¼g / ml to 0.5 Î¼g / ml. can. The detection antibody preferably comprises a labeling substance.

ãªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªã®æ¤åºã¯ãå ç«è¤åä½ã«å«ã¾ããæ¨è­ç©è³ªãæ¤åºãããã¨ã«ããè¡ããã¨ãã§ãããåè¨æ¨è­ç©è³ªã¯ãæ¤åºå¯è½ãªã·ã°ãã«ãçããéããç¹ã«éå®ãããªããä¾ãã°ãããèªä½ãã·ã°ãã«ãçºçããç©è³ªï¼ä»¥ä¸ããã·ã°ãã«çºçç©è³ªãã¨ãããï¼ã§ãã£ã¦ããããä»ã®ç©è³ªã®åå¿ãè§¦åªãã¦ã·ã°ãã«ãçºçãããç©è³ªã§ãã£ã¦ããããã·ã°ãã«çºçç©è³ªã¨ãã¦ã¯ãä¾ãã°ãèå ç©è³ªãæ¾å°æ§åä½å ç´ ç­ãæãããããä»ã®ç©è³ªã®åå¿ãè§¦åªãã¦æ¤åºå¯è½ãªã·ã°ãã«ãçºçãããç©è³ªã¨ãã¦ã¯ãä¾ãã°ãé µç´ ãæãããããé µç´ ã¨ãã¦ã¯ãã¢ã«ã«ãªãã¹ãã¡ã¿ã¼ã¼ããã«ãªã­ã·ãã¼ã¼ãÎ²ï¼ã¬ã©ã¯ãã·ãã¼ã¼ãã«ã·ãã§ã©ã¼ã¼ç­ãæãããããèå ç©è³ªã¨ãã¦ã¯ããã«ãªã¬ã»ã¤ã³ã¤ã½ããªã·ã¢ãã¼ãï¼ï¼¦ï¼©ï¼´ï¼£ï¼ãã­ã¼ããã³ãï¼¡ï½ï½ ï½ï½ ï¼¦ï½ï½ï½ï½ï¼ç»é²åæ¨ï¼ç­ã®èå è²ç´ ãï¼§ï¼¦ï¼°ç­ã®èå ã¿ã³ãã¯è³ªç­ãæãããããæ¾å°æ§åä½å ç´ ã¨ãã¦ã¯ãï¼ï¼ï¼ï¼©ãï¼ï¼ï¼£ãï¼ï¼ï¼°ç­ãæããããããããã®ä¸­ã§ããæ¨è­ç©è³ªã¨ãã¦ãé µç´ ãå¥½ã¾ãããÎ²ã¬ã©ã¯ãã·ãã¼ã¼ãç¹ã«å¥½ã¾ããã Phosphorylated tau protein can be detected by detecting a labeling substance contained in an immune complex. The labeling substance is not particularly limited as long as a detectable signal is generated. For example, the substance itself may be a substance that generates a signal (hereinafter, also referred to as a âsignal generating substanceâ), or may be a substance that catalyzes the reaction of another substance to generate a signal. Examples of the signal generating substance include a fluorescent substance, a radioisotope and the like. Examples of substances that catalyze the reaction of other substances to generate a detectable signal include enzymes. Examples of the enzyme include alkaline phosphatase, peroxidase, Î²-galactosidase, luciferase and the like. Examples of the fluorescent substance include fluorescent dyes such as fluorescein isothiocyanate (FITC), rhodamine and Alexa Fluor (registered trademark), and fluorescent proteins such as GFP. Examples of the radioisotope include 125 I, 14 C, 32 P and the like. Among them, an enzyme is preferable as a labeling substance, and Î²-galactosidase is particularly preferable.

é µç´ ã®åºè³ªã¯ãè©²é µç´ ã®ç¨®é¡ã«å¿ãã¦å ¬ç¥ã®åºè³ªããé©å®é¸æã§ãããä¾ãã°ãé µç´ ã¨ãã¦ã¢ã«ã«ãªãã¹ãã¡ã¿ã¼ã¼ãç¨ããå ´åãåºè³ªã¨ãã¦ãï¼£ï¼¤ï¼°ï¼ï¼³ï½ï½ï½ï¼ç»é²åæ¨ï¼ï¼ï¼ï¼ã¯ã­ã­ï¼ï¼ï¼ï¼ã¡ãã­ã·ã¹ãã­ï¼»ï¼ï¼ï¼ï¼ã¸ãªã­ã»ã¿ã³ï¼ï¼ï¼ï¼âï¼ï¼ï¼âï¼ã¯ã­ã­ï¼ããªã¯ã·ã­ï¼»ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼½ãã«ã³ï¼½ï¼ï¼ï¼ã¤ã«ï¼ãã§ãã«ãªã³é ¸ï¼ãããªã¦ã ï¼ãï¼£ï¼³ï¼°ï¼¤ï¼ç»é²åæ¨ï¼ï¼ï¼ï¼ï¼ï¼ï¼ã¡ãã­ã·ã¹ãã­ï¼»ï¼ï¼ï¼ï¼ã¸ãªã­ã»ã¿ã³ï¼ï¼ï¼ï¼ï¼ï¼ï¼âï¼ã¯ã­ã­ï¼ããªã·ã¯ã­ï¼»ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼½ãã«ã³ï¼½ï¼ï¼ï¼ã¤ã«ï¼ãã§ãã«ãªã³é ¸ï¼ãããªã¦ã ï¼ç­ã®åå­¦çºå åºè³ªãï¼ï¼ãã­ã¢ï¼ï¼ï¼ã¯ã­ã­ï¼ï¼ï¼ã¤ã³ããªã«ãªã³é ¸ï¼ï¼¢ï¼£ï¼©ï¼°ï¼ãï¼ï¼ãã­ã¢ï¼ï¼ï¼ã¯ã­ã­ï¼ã¤ã³ããªã«ãªã³é ¸ï¼ãããªã¦ã ãï½ï¼ããã­ãã§ãã«ãªã³é ¸ç­ã®çºè²åºè³ªãæãããããé µç´ ã¨ãã¦Î²ã¬ã©ã¯ãã·ãã¼ã¼ãä½¿ç¨ããå ´åã«ã¯ãã¬ã½ã«ãã£ã³Î²ï¼ï¼¤ï¼ã¬ã©ã¯ããã©ãã·ããä½¿ç¨ãããã¨ãã§ãããé µç´ ã¨ãã¦ããã«ãªã­ã·ãã¼ã¼ãç¨ããå ´åã«ã¯ãï¼´ï½ï½ ï½ï½ï½ ï¼¦ï½ï½ï½ï½ ï½ ï¼³ï¼£ï¼©ï¼¥ï¼®ï¼£ï¼¥ç¤¾ã®ï¼³ï½ï½ï½ ï½ï¼³ï½ï½ï½ï½ï½ ï¼¥ï¼¬ï¼©ï¼³ï¼¡ã·ãªã¼ãºç­ãä½¿ç¨ãããã¨ãã§ããããããé µç´ åå¿ã¯ããã¼ãºãå¾è¿°ãããã¤ã¯ã­ã¦ã§ã«ã«é ç½®ãã¦ããåã«è¡ããã¨ãå¥½ã¾ãããããã¼ãºããã¤ã¯ã­ã¦ã§ã«ã«é ç½®ãã¦ããé µç´ åå¿ãè¡ã£ã¦ãããã The substrate of the enzyme can be appropriately selected from known substrates according to the type of the enzyme. For example, when alkaline phosphatase is used as the enzyme, CDP-StarÂ® (4-chloro-3- (methoxyspiro [1,2-dioxetane-3,2'-(5'-chloro) trixilo] [ 3.3.1.13,7] decane] -4-yl) phenylphosphate disodium), CSPDÂ® (registered trademark) (3- (4-methoxyspiro [1,2-dioxetane-3,2- (5) Chemiluminescent substrate such as'-chloro) tricyclo [3.3.1.13,7] decane] -4-yl) phenylphosphate disodium), 5-bromo-4-chloro-3-indrill phosphate ( Examples thereof include chemiluminescent substrates such as BCIP), 5-bromo-6-chloro-indrill phosphate disodium, and p-nitrophenyl phosphate. When Î²-galactosidase is used as an enzyme, resorphin Î²-D-galactopyranoside can be used. When peroxidase is used as the enzyme, the SuperSignal ELISA series manufactured by Thermo Fisher SCIENCE can be used. It is preferable that these enzymatic reactions are carried out before the beads are placed in the microwells described later, but the enzymatic reactions may be carried out after the beads are placed in the microwells.

ã¾ããæ¤åºæä½ãããªãã³åãã¦ãããåè¨æ¨è­ç©è³ªãæ¨è­ããã¢ãã¸ã³åã¯ã¹ãã¬ããã¢ãã¸ã³ã¨çµåããã¦ãããåè¨ã·ã°ãã«ãæ¤åºãã¦ãããã Alternatively, the detection antibody may be biotinylated and the labeled substance may be bound to labeled avidin or streptavidin before detecting the signal.

ã·ã°ãã«ã®æ¤åºã¯ãæ¸¬å®è©¦æã«å«ã¾ãã¦ããææãã¼ãºåã³éææãã¼ãºãå«ããã¼ãºã«ã¤ãã¦ããã®å ¨é¨åã¯ä¸é¨ã«ã¤ãã¦è¡ããã¨ãã§ãããã·ã°ãã«ã®æ¤åºã¯åã ã®ãã¼ãºã«ã¤ãã¦è¡ããã¨ãå¥½ã¾ãããããã§ãææãã¼ãºã¨ãéææãã¼ãºã¨ã¯ããã®ã·ã°ãã«ã®æç¡ãå¼·å¼±ãæ³¢é·ç­ãç°ãªããããããããè­å¥ã§ããæ¤åºè£ ç½®ãä½¿ç¨ãããã¨ãå¥½ã¾ããã The detection of the signal can be performed on all or a part of the beads including the captured beads and the non-captured beads contained in the measurement sample. Signal detection is preferably performed on individual beads. Here, since the presence / absence, strength, wavelength, etc. of the signal are different between the captured beads and the non-captured beads, it is preferable to use a detection device capable of distinguishing them.

åã ã®ãã¼ãºã®ã·ã°ãã«ãæ¤åºããæ¹æ³ã¨ãã¦ã¯ãä¾ãã°ã·ã°ãã«ãèå ã§ããå ´åã«ã¯ããã­ã¼ãµã¤ãã¡ã¼ã¿ãç¨ãã¦æ¤åºãããã¨ãã§ããã As a method for detecting the signal of each bead, for example, when the signal is fluorescent, it can be detected by using a flow cytometer.

ã¾ããå¥ã®æ æ§ã¨ãã¦ãè¤æ°ã®ãã¤ã¯ã­ã¦ã§ã«ãæããåºæ¿ã«åè¨æ¸¬å®è©¦æãæ¥è§¦ããã¦ãåè¨æ¸¬å®è©¦æä¸­ã®ææãã¼ãºåã³éææãã¼ãºããåè¨ãã¤ã¯ã­ã¦ã§ã«ã«é ç½®ãã¦ããã¤ã¯ã­ã¦ã§ã«å ã®ã·ã°ãã«ãæ¤åºãã¦ãããã Further, as another embodiment, the measurement sample is brought into contact with a substrate having a plurality of microwells, and the captured beads and the non-captured beads in the measurement sample are arranged in the microwells to transmit a signal in the microwells. It may be detected.

åºæ¿ä¸ã«ããã¦ãã¤ã¯ã­ã¦ã§ã«ã¯ãå®è³ªçã«å¹³å¦ãªè¡¨é¢ä¸ã«ãåã¯éå¹³é¢ã®ï¼æ¬¡å é åã§é ç½®ããå¾ãããã¤ã¯ã­ã¦ã§ã«ã¯ãè¦åçãªãã¿ã¼ã³ã§é åããã¦ãã¦ãããããã©ã³ãã ã«åå¸ãã¦ãã¦ããããå¥½ã¾ããã¯ããã¤ã¯ã­ã¦ã§ã«ã¯ãå®è³ªçã«å¹³å¦ãªè¡¨é¢ä¸ã®é¨ä½ã®è¦åçãªãã¿ã¼ã³ã§ãããã¨ãå¥½ã¾ããã On the substrate, the microwells can be arranged on a substantially flat surface or in a non-planar three-dimensional array. The microwells may be arranged in a regular pattern or may be randomly distributed. Preferably, the microwells are a regular pattern of sites on a substantially flat surface.

åºæ¿ã«å«ã¾ãããã¤ã¯ã­ã¦ã§ã«ã®æ°ã¯ãï¼æ¸¬å®è©¦æãããï¼ï¼ï¼ï¼åããï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼åç¨åº¦ã¨ãããã¨ãã§ãããå¥½ã¾ããã¯ãåºæ¿ã¯ï¼ï¼ï¼ï¼ï¼ï¼åããï¼ï¼ï¼ï¼ï¼ï¼ï¼åãããå¥½ã¾ããã¯ï¼ï¼ï¼ï¼ï¼ï¼ï¼åããï¼ï¼ï¼ï¼ï¼ï¼ï¼åç¨åº¦ã®ãã¤ã¯ã­ã¦ã§ã«ãå«ããã¨ãã§ããã The number of microwells contained in the substrate can be about 1000 to 1,000,000 per measurement sample. Preferably, the substrate can contain from 10,000 to 500,000 microwells, more preferably from 100,000 to 500,000 microwells.

åè¨åºæ¿ã®ææã¯ãã¬ã©ã¹ï¼ä¿®é£¾åã³ï¼åã¯å®è½åã¬ã©ã¹ãå«ãï¼ããã©ã¹ããã¯ï¼ããªãã­ãã¬ã³ãããªã¨ãã¬ã³ãããªããã¬ã³ãããªã¦ã¬ã¿ã³ãç°ç¶ãªã¬ãã£ã³ã³ããªãã¼ï¼ï¼£ï¼¯ï¼£ï¼ãç°ç¶ãªã¬ãã£ã³ããªãã¼ï¼ï¼£ï¼¯ï¼°ï¼ãããã­ã³ï¼ç»é²åæ¨ï¼ãå¤ç³é¡ããã¤ã­ã³åã¯ããã­ã»ã«ã­ã¼ã¹ç­ï¼ãã¨ã©ã¹ããã¼ï¼ä¾ãã°ãã¸ã¡ãã«ã·ã­ã­ãµã³åã³ããªã¦ã¬ã¿ã³ç­ï¼ï¼ãè¤åææãã»ã©ããã¯ã¹ãã·ãªã«åã¯ã·ãªã«ç³»ææï¼ã±ã¤ç´ åã³å¤æ§ã·ãªã³ã³ãå«ãï¼ãç­ç´ ãéå±ãå ãã¡ã¤ãã¼æç­ããæ§æããããã The substrate material is glass (including modified and / or functionalized glass), plastic (polypropylene, polyethylene, polybutylene, polyurethane, cyclic olefin copolymer (COC), cyclic olefin polymer (COP), TeflonÂ®, poly. Consists of sugars, nylon or nitrocellulose, etc.), elastomers (eg, dimethylsiloxane and polyurethane, etc.), composite materials, ceramics, silica or silica-based materials (including silicon and modified silicon), carbon, metals, optical fiber bundles, etc. sell.

åã ã®ãã¤ã¯ã­ã¦ã§ã«ã®å®¹éã¯ããã¼ãºã®å¤§ããã«åããã¦ãé©å®è¨­å®ãããã¨ãã§ãããä¾ãã°ãï¼ã¦ã§ã«ã«åå®¹ããããã¼ãºã®æ°ã¯ï¼åããï¼åç¨åº¦ãå¥½ã¾ããã¯ï¼ããï¼åç¨åº¦ãããå¥½ã¾ããã¯ï¼åã§ããããã®ããããã¤ã¯ã­ã¦ã§ã«ã®å®¹ç©ã¯ãï¼ã¦ã§ã«ã«åè¨æ°ã®ãã¼ãºãåå®¹ãããå¤§ããã§ãããã¨ãå¥½ã¾ãããï¼ä¾ãã°ãç±³å½ç¹è¨±åºé¡å ¬éç¬¬ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼å·æç´°æ¸ãå½éå ¬éç¬¬ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼å·ï¼ãããå ·ä½çã«ã¯ããã¤ã¯ã­ã¦ã§ã«ã®å®¹ç©ã¯ãï¼ï¼ï¼ã¢ãããªããã«ããï¼ãã³ãªããã«ãå¥½ã¾ããã¯ï¼ãã§ã ããªããã«ããï¼ï¼ï¼ãã§ã ããªããã«ãããå¥½ã¾ããã¯ï¼ï¼ãã§ã ããªããã«ããï¼ï¼ãã§ã ããªããã«ã®ç¯å²ã§ãããï¼ã¤ã®åºæ¿ä¸ã«å­å¨ããè¤æ°ã®ãã¤ã¯ã­ã¦ã§ã«ã¯ããããããã»ã¼åãå®¹ç©ãæãããã¨ãå¥½ã¾ããã The capacity of each microwell can be appropriately set according to the size of the beads. For example, the number of beads housed in one well is about 1 to 5, preferably about 1 to 2, and more preferably about 1. Therefore, the volume of the microwells is preferably large enough to accommodate the number of beads in one well. (For example, US Patent Application Publication No. 2011/0212848, International Publication No. 2011/109364). More specifically, the volume of microwells ranges from 100 at liters to 1 picolitre, preferably from 1 femtolitre to 500 femtolitres, more preferably from 10 femtolitres to 90 femtolitres. It is preferred that the plurality of microwells present on one substrate each have approximately the same volume.

åè¨ãã¤ã¯ã­ã¦ã§ã«ã®å½¢ææ¹æ³ã¯ãææã®å¤§ããã®ãã¤ã¯ã­ã¦ã§ã«ãå½¢æã§ããéãå¶éãããªããä¾ãã°ããã©ããªã½ã°ã©ãã£ã¼ãã¹ã¿ã³ãã³ã°æè¡ãæå½¢æè¡ãã¨ããã³ã°æè¡ç­ã®å ¬ç¥ã®æ¹æ³ã«ããå½¢æãããã¨ãã§ããã The method for forming microwells is not limited as long as microwells of a desired size can be formed. For example, it can be formed by a known method such as photolithography, stamping technique, molding technique, etching technique and the like.

ãã¤ã¯ã­ã¦ã§ã«å ã¸ã®ãã¼ãºã®é ç½®ã¯ãå ¬ç¥ã®æ¹æ³ãä½¿ç¨ãã¦è¡ããã¨ãã§ããã ä¾ãã°ãç¹è¨±æç®ï¼ã«è¨è¼ã®ãã¤ã¯ã­æµä½æè¡ãç¨ãã¦ãã¤ã¯ã­ã¦ã§ã«å ã«ãã¼ãºãé ç½®ãããã¨ãã§ãããããã§ããã¼ãºã¯ãåºæ¿ä¸ã®ãã¤ã¯ã­ã¦ã§ã«ã®å ¨ã¦ã«é ç½®ããã¦ããããä¸é¨ã«é ç½®ããã¦ãããã The placement of the beads in the microwells can be done using known methods. For example, beads can be placed in microwells using the microfluidic technique described in Patent Document 1. Here, the beads may be arranged in all of the microwells on the substrate, or may be arranged in a part thereof.

ä¾ãã°ãæ¸¬å®è©¦æããã¤ã¯ã­ã¦ã§ã«ãè¨­è¨ãããåºæ¿ã«æ¥è§¦ãããå¾ãåºæ¿åã³æº¶æ¶²ãé å¿ãã¦ããã¼ãºããã¤ã¯ã­ã¦ã§ã«é ç½®ãããã¨ãã§ããããã¼ãºãç£æ°ã§ããå ´åãç£ç³ãä½¿ç¨ãã¦ãã¼ãºããã¤ã¯ã­ã¦ã§ã«ã«é ç½®ãã¦ãããããããã¯ããã¤ã¯ã­ã¦ã§ã«ãå ãã¡ã¤ãã¼æã®ç«¯é¨ã«å½¢æããã¦ããå ´åãå ãã¡ã¤ãã¼ã®ããä¸ç«¯ã®å¨ãã«æ¸¬å®è©¦æãæ¥è§¦ãããå¾ãé å¿åãå§åç­ã®åãå ãã¦ããã¤ã¯ã­ã¦ã§ã«ã«ãã¼ãºãé ç½®ãã¦ãããã For example, after the measurement sample is brought into contact with the substrate on which the microwell is designed, the substrate and solution can be centrifuged to place the beads in the microwell. If the beads are magnetic, magnets may be used to place the beads in the microwells. Alternatively, if the microwell is formed at the end of the optical fiber bundle, the measurement sample is brought into contact with the other end of the optical fiber, and then centrifugal force, pressure, or other force is applied to place the beads in the microwell. You may.

ãã¼ãºããã¤ã¯ã­ã¦ã§ã«ã«é ç½®ããå¾ããã¤ã¯ã­ã¦ã§ã«ã®å¨å²ã®åºæ¿ã«æ®ã£ãæ¸¬å®è©¦æãé¤å»ããåºæ¿ã®è¡¨é¢ãæ´æµåã³ï¼åã¯æ­ãåã£ã¦ä½åãªæ¸¬å®è©¦æãé¤å»ãã¦ãããã

ä¸è¨ãã¤ã¯ã­ã¦ã§ã«ãå«ãåºæ¿ã¨ãã¦ã¯ãä¾ãã°ãï¼±ï½ï½ï½ï½ï½ ï½ï½ï½ç¤¾ã®ï¼³ï½ï½ï½ï½ï¼´ï¼­ ï¼¤ï½ï½ï½ãä½¿ç¨ãããã¨ãã§ããã After placing the beads in the microwell, the measurement sample remaining on the substrate around the microwell may be removed, and the surface of the substrate may be washed and / or wiped to remove the excess measurement sample.

As the substrate containing the microwell, for example, Quantix's Simoa TM Disk can be used.

ã¾ãããã¼ãºãé ç½®ããå¾ã®ãã¤ã¯ã­ã¦ã§ã«ã¯ããã«ãªã©ã¹æ¶²ä½ãæ²¹ï¼ä¾ãã°ãé±æ²¹ãããç´ åæ²¹ï¼ãå¼·ç£æ§æµä½ãéæ°´æ§ããªãã¼æº¶æ¶²ï¼ä¾ãã°ãå¢ç²å¤ï¼ç­ã§ã·ã¼ã«ããã¦ããããåè¨ã·ã¼ã«ã«ã¯ãä¾ãã°ãï¼±ï½ï½ï½ï½ï½ ï½ï½ï½ç¤¾ã®ï¼³ï½ï½ï½ï½ï¼´ï¼­ ï¼³ï½ ï½ï½ï½ï½ï½ ï¼¯ï½ï½ãä½¿ç¨ãã¦ãããã Further, the microwell after placing the beads may be sealed with a fluorous liquid, an oil (for example, mineral oil, fluorinated oil), a ferromagnetic fluid, a non-aqueous polymer solution (for example, a thickener) or the like. For the seal, for example, Simoa TM Sealing Oil manufactured by Quantlix may be used.

ãã¤ã¯ã­ã¦ã§ã«ã«é ç½®ããããã¼ãºã®æ¤åºã¯ãä¾ãã°æ¨è­ç©è³ªãé µç´ ãèå è²ç´ ã§ããå ´åã«ã¯ãï¼£ï¼£ï¼¤ã«ã¡ã©ç­ã§ãã·ã°ãã«ãæ®åãããã¨ã«ããè¡ããã¨ãã§ãããã¾ããæ¨è­ç©è³ªãæ¾å°æ§åä½å ç´ ã§ããå ´åã«ã¯ããªã¼ãã©ã¸ãªã°ã©ãã£ã¼ãä½¿ç¨ãã¦æ¤åºãããã¨ãã§ããã The beads arranged in the microwells can be detected, for example, by imaging a signal with a CCD camera or the like when the labeling substance is an enzyme or a fluorescent dye. Also, if the labeling substance is a radioisotope, it can be detected using autoradiography.

ãã¤ã¯ã­ã¦ã§ã«ã«é ç½®ããããã¼ãºã¯ãææãã¼ãºãåã¯éææãã¼ãºã§ããããæ¨çã¿ã³ãã¯è³ªãææããææãã¼ãºã¯ãåè¨æ¨è­ç©è³ªã«ç±æ¥ããã·ã°ãã«ï¼ããªãã¡ãåè¨å ç«è¤åä½ã«ç±æ¥ããã·ã°ãã«ï¼ãçºããã®ã«å¯¾ãã¦ãæ¨çã¿ã³ãã¯è³ªãææããªãã£ããã¼ãºåã³éææãã¼ãºã¯ãåè¨æ¨è­ç©è³ªã«ç±æ¥ããã·ã°ãã«ãçºããªãããã®ãããåè¨æ¨è­ç©è³ªã«ç±æ¥ããã·ã°ãã«ãçºããã¦ã§ã«ã®æ°ãè¨æ°ãããã¨ã«ãã£ã¦ãæ¨çã¿ã³ãã¯è³ªãå®éãããã¨ãã§ãããã·ã°ãã«ãæ¤åºãããã¤ã¯ã­ã¦ã§ã«ã¯ãåºæ¿ä¸ã®å ¨ã¦ã®ãã¤ã¯ã­ã¦ã§ã«ã§ãã£ã¦ããããä¸é¨ã§ãããã The beads placed in the microwell are captive beads or non-capture beads, but the captive beads that capture the target protein emit a signal derived from the labeling substance (that is, a signal derived from the immune complex). On the other hand, the beads that did not capture the target protein and the non-captured beads do not emit a signal derived from the labeling substance. Therefore, the target protein can be quantified by counting the number of wells that emit a signal derived from the labeling substance. The microwells that detect the signal may be all microwells on the substrate or may be partial.

åè¨æ¨è­ç©è³ªã«ç±æ¥ããã·ã°ãã«ãçºããã¦ã§ã«ã®æ°ã¯ãä¾ãã°ãï¼±ï½ï½ï½ï½ï½ ï½ï½ï½ç¤¾ã®ï¼³ï½ï½ï½ï½ï¼´ï¼­ ï¼¨ï¼¤ï¼ï¼ ï¼¡ï½ï½ï½ï½ï½ï½ ï½ã§æ¸¬å®ãããã¨ãã§ãããï¼³ï½ï½ï½ï½ï¼´ï¼­ ï¼¨ï¼¤ï¼ï¼ ï¼¡ï½ï½ï½ï½ï½ï½ ï½ãä½¿ç¨ããå ´åãã·ã°ãã«ã®å¼·ãã¯ããã¼ãºãããã®å¹³åé µç´ ï¼ï¼¡ï¼¥ï¼¢ï¼å¤ã¨ãã¦è¡¨ãããããã®ãããï¼¡ï¼¥ï¼¢å¤ãæ¸¬å®è©¦æä¸­ã®å ç«è¤åä½ã«ç±æ¥ããã·ã°ãã«å¼·åº¦ã¨ãã¦ãããã The number of wells emitting a signal derived from the labeling substance can be measured, for example, with Quantix's Simoa TM HD-1 Analyzer. When using the Simoa TM HD-1 Analyzer, the signal intensity is expressed as the average enzyme (AEB) value per bead. Therefore, the AEB value may be used as the signal intensity derived from the immune complex in the measurement sample.

ã¾ããæ¤éç·ãç¨ãã¦ãï¼¡ï¼¥ï¼¢å¤ããªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªã®æ¸¬å®å¤ã«æç®ãã¦ããããããã§ãªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªã®æ¸¬å®å¤ã¨ã¯ããªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªï¼ã®éåã¯æ¿åº¦ãåæ ããå¤ããããå½è©²æ¸¬å®å¤ããéãã§æ¨è¨ããå ´åã«ã¯ãã¢ã«ã§ãã£ã¦ãè³ªéã§ãã£ã¦ãããããè³ªéã§æ¨è¨ãããã¨ãå¥½ã¾ãããã¾ããå¤ããæ¿åº¦ãã§è¡¨è¨ããå ´åã«ã¯ãã¢ã«æ¿åº¦ã§ãã£ã¦ãçä½è©¦æã®ä¸å®å®¹éãããã®è³ªéã®å²åï¼è³ªéï¼å®¹éï¼ã§ãã£ã¦ãããããå¥½ã¾ããã¯è³ªéï¼å®¹éã§ããã Further, the AEB value may be converted into the measured value of the phosphorylated tau protein using the calibration curve. Here, the measured value of phosphorylated tau protein means a value that reflects the amount or concentration of phosphorylated tau protein. When the measured value is marked as "amount", it is a mass even if it is mol. However, it is preferable to indicate by mass. Further, when the value is expressed by "concentration", it is the ratio of mass (mass / volume) per fixed volume of the biological sample even if it is a molar concentration. It may be, but preferably mass / volume.

æ¬å®æ½æ æ§ã®æ¸¬å®æ¹æ³ã¨ãã¦ã¯ãï¼±ï½ï½ï½ï½ï½ ï½ï½ï½ç¤¾ã®ãã­ãã³ã¼ã«ã«ãããã£ã¦ãæ¨è­ç©è³ªã¨ãã¦Î²ã¬ã©ã¯ãã·ãã¼ã¼ãç¨ããã¬ã½ã«ãã£ã³Î²ï¼ï¼¤ï¼ã¬ã©ã¯ããã©ãã·ããåºè³ªã¨ãã¦ç¨ãããã¨ãå¥½ã¾ãããã¾ãããã¼ãºã¯ï¼³ï½ï½ï½ï½ï¼´ï¼­ ï¼¤ï½ï½ï½ã«ã¢ãã©ã¤ãããï¼³ï½ï½ï½ï½ï¼´ï¼­ ï¼¨ï¼¤ï¼ï¼ ï¼¡ï½ï½ï½ï½ï½ï½ ï½ã§ã·ã°ãã«å¼·åº¦ãåå¾ãããã¨ãå¥½ã¾ããã As the measuring method of this embodiment, it is preferable to use Î²-galactosidase as a labeling substance and resorphin Î²-D-galactopyranoside as a substrate according to the protocol of Quantlix. Further, it is preferable that the beads are applied to Simoa TM Disk and the signal intensity is obtained by Simoa TM HD-1 Analyzer.

ï¼»ï¼ï¼ã¢ã«ããã¤ãã¼ç ã«ç½¹æ£ãã¦ãããå¦ãã®æ å ±ãåå¾ããæ¹æ³ï¼½

æ¬çºæã®ç¬¬ï¼ã®å®æ½æ æ§ã¯ãä¸è¨ï¼ï¼ã§åå¾ããããªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªã®ã·ã°ãã«ã®å¼·åº¦ã«åºã¥ãã¦ãåè¨è¢«é¨è ãã¢ã«ããã¤ãã¼ç ã«ç½¹æ£ãã¦ãããå¦ãã®æ å ±ãåå¾ããã [2. How to get information about whether you have Alzheimer's disease]

The second embodiment of the present invention is described in the above 1. Based on the signal intensity of the phosphorylated tau protein obtained in, information on whether or not the subject has Alzheimer's disease is acquired.

ããå ·ä½çã«ã¯ãåè¨è¢«é¨è ã®çä½è©¦æä¸­ã®ãªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªã«ç±æ¥ããã·ã°ãã«å¼·åº¦ãæå®ã®åºæºå¤ã¨æ¯è¼ããåè¨è¢«é¨è ã®çä½è©¦æä¸­ã®ãªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªã«ç±æ¥ããã·ã°ãã«å¼·åº¦ãé«ãå ´åã«ãåè¨è¢«é¨è ãã¢ã«ããã¤ãã¼ç ã«ç½¹æ£ãã¦ããã¨ããæ å ±ãåå¾ããã More specifically, when the signal intensity derived from the phosphorylated tau protein in the biological sample of the subject is compared with a predetermined reference value, and the signal intensity derived from the phosphorylated tau protein in the biological sample of the subject is high. In addition, the subject obtains information that he / she has Alzheimer's disease.

ããã§ãæå®ã®åºæºå¤ã¨ã¯ããªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªã«ç±æ¥ããã·ã°ãã«å¼·åº¦ã®åºæºå¤ããããåè¨åºæºå¤ã¯ãã¢ã«ããã¤ãã¼ç åã³ï¼åã¯è»½åº¦èªç¥çãçºçãã¦ããªãè ã®çä½è©¦æä¸­ã®ãªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªã«ç±æ¥ããã·ã°ãã«å¼·åº¦ï¼é°æ§å¯¾ç §å¤ï¼ã«åºã¥ãã¦æ±ºå®ãããã¨ãã§ããããããã¯ã¢ã«ããã¤ãã¼ç ãçºçããè ã®çä½è©¦æä¸­ã®ãªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªã«ç±æ¥ããã·ã°ãã«å¼·åº¦ï¼é½æ§å¯¾ç §å¤ï¼ã«åºã¥ãã¦æ±ºå®ãããã¨ãã§ãããã¾ããåºæºå¤ã¯ãé°æ§å¯¾ç §å¤åã³é½æ§å¯¾ç §å¤ã®åæ¹ããæ±ºå®ãã¦ããããä¾ãã°ãè¤æ°ã®é½æ§å¯¾ç §å¤ã¨ãè¤æ°ã®é°æ§å¯¾ç §å¤ã¨ãåå¾ãããããã®è¤æ°ã®å¤ã«åºã¥ãã¦é½æ§ã¨é°æ§ã¨ãæãç²¾åº¦ããåé¡ã§ããå¤ããåºæºå¤ãã¨ãããã¨ãã§ãããããã§ããæãç²¾åº¦ããåé¡ã§ããå¤ãã¯ãæ¤æ»ã®ç®çã«ãã£ã¦æåº¦ãç¹ç°åº¦ãé½æ§çä¸­çãé°æ§çä¸­çç­ã®ææ¨ã«åºã¥ãã¦é©å®è¨­å®ãããã¨ãã§ãããã¾ããå¥ã®ä¾ã§ã¯ãæåº¦ãç¹ç°åº¦ãé°æ§çä¸­çãé½æ§çä¸­çç­ã®è¦³ç¹ããé½æ§ã¨é°æ§ã¨ãæãç²¾åº¦è¯ãåé¡ã§ããåºæºå¤ãè¨­å®ãããã¨ãã§ããã Here, the predetermined reference value means a reference value of signal intensity derived from phosphorylated tau protein. The reference value can be determined based on the signal intensity (negative control value) derived from the phosphorylated tau protein in the biological sample of a person who has not developed Alzheimer's disease and / or mild dementia. Alternatively, it can be determined based on the signal intensity (positive control value) derived from the phosphorylated tau protein in the biological sample of a person who has developed Alzheimer's disease. Further, the reference value may be determined from both the negative control value and the positive control value. For example, a plurality of positive control values and a plurality of negative control values can be obtained, and a value capable of most accurately classifying positive and negative based on these plurality of values can be set as a "reference value". Here, the "value that can be classified most accurately" can be appropriately set based on an index such as sensitivity, specificity, positive predictive value, and negative predictive value, depending on the purpose of the test. In another example, it is possible to set a reference value capable of classifying positive and negative with the highest accuracy from the viewpoint of sensitivity, specificity, negative predictive value, positive predictive value, and the like.

ããã§ãåè¨ã·ã°ãã«å¼·åº¦ã«ä»£ãã¦ããªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªã®æ¸¬å®å¤ãç¨ãã¦ãåè¨è¢«é¨è ãã¢ã«ããã¤ãã¼ç ã«ç½¹æ£ãã¦ãããå¦ãã®æ å ±ãåå¾ãã¦ãããã Here, instead of the signal intensity, the measured value of phosphorylated tau protein may be used to obtain information on whether or not the subject has Alzheimer's disease.

ï¼»ï¼ï¼ãªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªãæ¸¬å®ããè£ ç½®ãã¢ã«ããã¤ãã¼ç ã§ãããå¦ãã®æ å ±ãåå¾ããè£ ç½®ï¼½

æ¬çºæã®ç¬¬ï¼ã®å®æ½æ æ§ã¯ãå°ãªãã¨ãå¦çé¨ï¼ï¼ãåãããè¢«é¨è ããæ¡åãããçä½è©¦æä¸­ã®ãªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªãæ¸¬å®ããè£ ç½®ï¼ä»¥ä¸ãæ¸¬å®è£ ç½®ã¨ããï¼ï¼ï¼ã«é¢ãããã¾ããç¬¬ï¼ã®å®æ½æ æ§ã¯ãæ¸¬å®è£ ç½®ï¼ï¼ã¨ãæ¸¬å®ã¦ãããï¼ï¼ã¨ãåãããè¢«é¨è ããæ¡åãããçä½è©¦æä¸­ã®ãªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªãæ¸¬å®ããã·ã¹ãã ï¼ï¼ï¼ã§ãã£ã¦ãããã [3. A device for measuring phosphorylated tau protein, a device for acquiring information on whether or not Alzheimer's disease is present]

A third embodiment of the present invention relates to an apparatus (hereinafter referred to as a measuring apparatus) 20 for measuring phosphorylated tau protein in a biological sample collected from a subject, which comprises at least a processing unit 21. Further, the third embodiment may be a system 200 for measuring phosphorylated tau protein in a biological sample collected from a subject, which comprises a measuring device 20 and a measuring unit 40.

ããã«ãæ¬çºæã®ç¬¬ï¼ã®å®æ½æ æ§ã¯ãå°ãªãã¨ãå¦çé¨ï¼ï¼ãåãããè¢«é¨è ããæ¡åãããçä½è©¦æä¸­ã®ãªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªã®ã·ã°ãã«å¼·åº¦ã«åºã¥ãã¦ãåè¨è¢«é¨è ãã¢ã«ããã¤ãã¼ç ã§ãããå¦ãã®æ å ±ãåå¾ããè£ ç½®ï¼ä»¥ä¸ãæ å ±åå¾è£ ç½®ã¨ããï¼ï¼ï¼ã«é¢ãããã¾ããç¬¬ï¼ã®å®æ½æ æ§ã¯ãæ å ±åå¾è£ ç½®ï¼ï¼ã¨ãæ¸¬å®ã¦ãããï¼ï¼ã¨ãåãããè¢«é¨è ããæ¡åãããçä½è©¦æä¸­ã®ãªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªã®ã·ã°ãã«å¼·åº¦ã«åºã¥ãã¦ãåè¨è¢«é¨è ãã¢ã«ããã¤ãã¼ç ã§ãããå¦ãã®æ å ±ãåå¾ããã·ã¹ãã ï¼ï¼ï¼ã§ãã£ã¦ãããã Further, a fourth embodiment of the present invention is whether or not the subject has Alzheimer's disease based on the signal intensity of the phosphorylated tau protein in the biological sample collected from the subject, which comprises at least the processing unit 51. The present invention relates to a device (hereinafter referred to as an information acquisition device) 50 for acquiring information. Further, in the fourth embodiment, whether the subject has Alzheimer's disease based on the signal intensity of the phosphorylated tau protein in the biological sample collected from the subject, which comprises the information acquisition device 50 and the measurement unit 40. It may be a system 500 that acquires information as to whether or not it is.

ç¬¬ï¼åã³ç¬¬ï¼ã®å®æ½æ æ§ã«ããã¦ãä¸è¨ï¼ï¼åã³ï¼ï¼ã§æ¢ã«èª¬æããã¦ããç¨èªã«ã¤ãã¦ã¯ãèª¬æãçç¥ããããä¸è¨ï¼ï¼åã³ï¼ï¼ã«ãããåç¨èªã«ã¤ãã¦ã®èª¬æã¯ãç¬¬ï¼ã®å®æ½æ æ§ã«ãæ´ç¨ãããã In the third and fourth embodiments, the above 1. And 2. The terms already explained in the above 1. And 2. The description of each term in the above is also incorporated in the second embodiment.

ï¼»ï¼ï¼ï¼ï¼æ¸¬å®è£ ç½®ã®æ§æï¼½

å³ï¼ã«ãæ¸¬å®è£ ç½®ï¼ï¼ã®ãã¼ãã¦ã§ã¢ã®æ§æãç¤ºããæ¸¬å®è£ ç½®ï¼ï¼ã¯ãå ¥åé¨ï¼ï¼ã¨ãåºåé¨ï¼ï¼ã¨ãè¨æ¶åªä½ï¼ï¼ã¨æ¥ç¶ããã¦ãã¦ãããã [3-1. Measuring device configuration]

FIG. 1 shows the hardware configuration of the measuring device 20. The measuring device 20 may be connected to the input unit 30, the output unit 31, and the storage medium 32.

æ¸¬å®è£ ç½®ï¼ï¼ã«ããã¦ãå¦çé¨ï¼ï¼£ï¼°ï¼µï¼ï¼ï¼ã¨ãä¸»è¨æ¶é¨ï¼ï¼ã¨ãï¼²ï¼¯ï¼­ï¼ï½ï½ ï½ï½ ï½ï½ï½ï½ ï½ï½ ï½ï½ï½ï½ï¼ï¼ï¼ã¨ãè£å©è¨æ¶é¨ï¼ï¼ã¨ãéä¿¡ã¤ã³ã¿ãã§ã¼ã¹ï¼ï¼©ï¼ï¼¦ï¼ï¼ï¼ã¨ãå ¥åã¤ã³ã¿ãã§ã¼ã¹ï¼ï¼©ï¼ï¼¦ï¼ï¼ï¼ã¨ãåºåã¤ã³ã¿ãã§ã¼ã¹ï¼ï¼©ï¼ï¼¦ï¼ï¼ï¼ã¨ãã¡ãã£ã¢ã¤ã³ã¿ã¼ãã§ã¼ã¹ï¼ï¼©ï¼ï¼¦ï¼ï¼ï¼ã¯ããã¹ï¼ï¼ã«ãã£ã¦äºãã«ãã¼ã¿éä¿¡å¯è½ã«æ¥ç¶ããã¦ããã In the measuring device 20, the processing unit (CPU) 21, the main storage unit 22, the ROM (read only memory) 23, the auxiliary storage unit 24, the communication interface (I / F) 28, and the input interface (I / F). ) 25, the output interface (I / F) 26, and the media interface (I / F) 27 are connected to each other by a bus 29 so as to be capable of data communication.

ï¼£ï¼°ï¼µï¼ï¼ã¯ãæ¸¬å®è£ ç½®ï¼ï¼ã®å¦çé¨ã§ãããï¼£ï¼°ï¼µï¼ï¼ããè£å©è¨æ¶é¨ï¼ï¼åã¯ï¼²ï¼¯ï¼­ï¼ï¼ã«è¨æ¶ããã¦ããã³ã³ãã¥ã¼ã¿ãã­ã°ã©ã ãå®è¡ããåå¾ããããã¼ã¿ã®å¦çãè¡ããã¨ã«ãããæ¸¬å®è£ ç½®ï¼ï¼ãæ©è½ããã The CPU 21 is a processing unit of the measuring device 20. The measuring device 20 functions by the CPU 21 executing a computer program stored in the auxiliary storage unit 24 or the ROM 23 and processing the acquired data.

ï¼²ï¼¯ï¼­ï¼ï¼ã¯ããã¹ã¯ï¼²ï¼¯ï¼­ãï¼°ï¼²ï¼¯ï¼­ãï¼¥ï¼°ï¼²ï¼¯ï¼­ãï¼¥ï¼¥ï¼°ï¼²ï¼¯ï¼­ç­ã«ãã£ã¦æ§æãããï¼£ï¼°ï¼µï¼ï¼ã«ããå®è¡ãããã³ã³ãã¥ã¼ã¿ãã­ã°ã©ã åã³ããã«ç¨ãããã¼ã¿ãè¨é²ããã¦ãããï¼£ï¼°ï¼µï¼ï¼ã¯ï¼­ï¼°ï¼µï¼ï¼ã¨ãã¦ããããï¼²ï¼¯ï¼­ï¼ï¼ã¯ãæ¸¬å®è£ ç½®ï¼ï¼ã®èµ·åæã«ãï¼£ï¼°ï¼µï¼ï¼ã«ãã£ã¦å®è¡ããããã¼ããã­ã°ã©ã ãæ¸¬å®è£ ç½®ï¼ï¼ãã¼ãã¦ã§ã¢ã®åä½ã«é¢é£ãããã­ã°ã©ã ãè¨­å®ãè¨æ¶ããã The ROM 23 is composed of a mask ROM, a PROM, an EPROM, an EEPROM, and the like, and records a computer program executed by the CPU 21 and data used for the computer program. The CPU 21 may be the MPU 21. The ROM 23 stores a boot program executed by the CPU 21 when the measuring device 20 is started, and programs and settings related to the operation of the measuring device 20 hardware.

ä¸»è¨æ¶é¨ï¼ï¼ã¯ãï¼³ï¼²ï¼¡ï¼­åã¯ï¼¤ï¼²ï¼¡ï¼­ç­ã®ï¼²ï¼¡ï¼­ï¼ï¼²ï½ï½ï½ï½ï½ ï½ï½ï½ï½ ï½ï½ ï½ï½ ï½ï½ï½ï½ï¼ã«ãã£ã¦æ§æããããä¸»è¨æ¶é¨ï¼ï¼ã¯ãï¼²ï¼¯ï¼­ï¼ï¼åã³è£å©è¨æ¶é¨ï¼ï¼ã«è¨é²ããã¦ããã³ã³ãã¥ã¼ã¿ãã­ã°ã©ã ã®èª­ã¿åºãã«ç¨ãããããã¾ããä¸»è¨æ¶é¨ï¼ï¼ã¯ãï¼£ï¼°ï¼µï¼ï¼ããããã®ã³ã³ãã¥ã¼ã¿ãã­ã°ã©ã ãå®è¡ããã¨ãã®ä½æ¥­é åã¨ãã¦å©ç¨ãããã The main storage unit 22 is composed of a RAM (Random access memory) such as a SRAM or a DRAM. The main storage unit 22 is used to read out the computer program recorded in the ROM 23 and the auxiliary storage unit 24. Further, the main storage unit 22 is used as a work area when the CPU 21 executes these computer programs.

è£å©è¨æ¶é¨ï¼ï¼ã¯ããã¼ããã£ã¹ã¯ããã©ãã·ã¥ã¡ã¢ãªç­ã®åå°ä½ã¡ã¢ãªç´ å­ãå ãã£ã¹ã¯ç­ã«ãã£ã¦æ§æããããè£å©è¨æ¶é¨ï¼ï¼ã«ã¯ããªãã¬ã¼ãã£ã³ã°ã·ã¹ãã åã³ã¢ããªã±ã¼ã·ã§ã³ãã­ã°ã©ã ç­ã®ãï¼£ï¼°ï¼µï¼ï¼ã«å®è¡ãããããã®ç¨®ã ã®ã³ã³ãã¥ã¼ã¿ãã­ã°ã©ã åã³ã³ã³ãã¥ã¼ã¿ãã­ã°ã©ã ã®å®è¡ã«ç¨ããåç¨®è¨­å®ãã¼ã¿ãè¨æ¶ããã¦ãããå ·ä½çã«ã¯ãè£å©è¨æ¶é¨ï¼ï¼ã¯ãå¾è¿°ããæ¸¬å®ãã­ã°ã©ã ãã·ã°ãã«å¼·åº¦ã®åºæºå¤ããªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªã®æ¸¬å®å¤ã®åºæºå¤ç­ãè¨æ¶ããã The auxiliary storage unit 24 is composed of a hard disk, a semiconductor memory element such as a flash memory, an optical disk, or the like. The auxiliary storage unit 24 stores various computer programs such as an operating system and an application program to be executed by the CPU 21, and various setting data used for executing the computer programs. Specifically, the auxiliary storage unit 24 stores a measurement program described later, a reference value of signal intensity, a reference value of a measured value of phosphorylated tau protein, and the like.

éä¿¡ï¼©ï¼ï¼¦ï¼ï¼ã¯ãï¼µï¼³ï¼¢ãï¼©ï¼¥ï¼¥ï¼¥ï¼ï¼ï¼ï¼ãï¼²ï¼³ï¼ï¼ï¼ï¼ï¼£ç­ã®ã·ãªã¢ã«ã¤ã³ã¿ãã§ã¼ã¹ãï¼³ï¼£ï¼³ï¼©ãï¼©ï¼¤ï¼¥ãï¼©ï¼¥ï¼¥ï¼¥ï¼ï¼ï¼ï¼ç­ã®ãã©ã¬ã«ã¤ã³ã¿ãã§ã¼ã¹ãåã³ï¼¤ï¼ï¼¡å¤æå¨ãï¼¡ï¼ï¼¤å¤æå¨ç­ãããªãã¢ãã­ã°ã¤ã³ã¿ãã§ã¼ã¹ããããã¯ã¼ã¯ã¤ã³ã¿ãã§ã¼ã¹ã³ã³ãã­ã¼ã©ï¼ï¼®ï½ ï½ï½ï½ï½ï½ ï½ï½ï½ï½ ï½ï½ï½ï½ï½ ï½ï½ï½ï½ï½ï½ï½ï½ï½ ï½ï¼ï¼®ï¼©ï¼£ï¼ç­ããæ§æããããéä¿¡ï¼©ï¼ï¼¦ï¼ï¼ã¯ãï¼£ï¼°ï¼µï¼ï¼ã®å¶å¾¡ä¸ã§ãæ¸¬å®ã¦ãããï¼ï¼åã¯ä»ã®å¤é¨æ©å¨ããã®ãã¼ã¿ãåä¿¡ããå¿ è¦ã«å¿ãã¦æ¸¬å®è£ ç½®ï¼ï¼ãä¿å­åã¯çæããæ å ±ããæ¸¬å®ã¦ãããï¼ï¼åã¯å¤é¨ã«éä¿¡åã¯è¡¨ç¤ºãããéä¿¡ï¼©ï¼ï¼¦ï¼ï¼ã¯ããããã¯ã¼ã¯ãä»ãã¦æ¸¬å®ã¦ãããï¼ï¼åã¯ä»ã®å¤é¨æ©å¨ã¨éä¿¡ãè¡ã£ã¦ãããã The communication I / F28 includes a serial interface such as USB, IEEE1394, RS-232C, a parallel interface such as SCSI, IDE, IEEE1284, an analog interface including a D / A converter, an A / D converter, and a network interface controller ( It is composed of Network interface controller (NIC) and the like. The communication I / F 28 receives data from the measuring unit 40 or another external device under the control of the CPU 21, and transmits or generates information stored or generated by the measuring device 20 to the measuring unit 40 or the outside as needed. indicate. The communication I / F 28 may communicate with the measurement unit 40 or another external device via the network.

å ¥åï¼©ï¼ï¼¦ï¼ï¼ã¯ãä¾ãã°ï¼µï¼³ï¼¢ãï¼©ï¼¥ï¼¥ï¼¥ï¼ï¼ï¼ï¼ãï¼²ï¼³ï¼ï¼ï¼ï¼ï¼£ç­ã®ã·ãªã¢ã«ã¤ã³ã¿ãã§ã¼ã¹ãï¼³ï¼£ï¼³ï¼©ãï¼©ï¼¤ï¼¥ãï¼©ï¼¥ï¼¥ï¼¥ï¼ï¼ï¼ï¼ç­ã®ãã©ã¬ã«ã¤ã³ã¿ãã§ã¼ã¹ãåã³ï¼¤ï¼ï¼¡å¤æå¨ãï¼¡ï¼ï¼¤å¤æå¨ç­ãããªãã¢ãã­ã°ã¤ã³ã¿ãã§ã¼ã¹ç­ããæ§æããããå ¥åï¼©ï¼ï¼¦ï¼ï¼ã¯ãå ¥åé¨ï¼ï¼ã¯æå­å ¥åãã¯ãªãã¯ãé³å£°å ¥åç­ãåãä»ãããåãä»ããå ¥åå å®¹ã¯ãä¸»è¨æ¶é¨ï¼ï¼åã¯è£å©è¨æ¶é¨ï¼ï¼ã«è¨æ¶ãããã The input I / F25 is composed of, for example, a serial interface such as USB, IEEE1394, RS-232C, a parallel interface such as SCSI, IDE, and IEEE1284, and an analog interface composed of a D / A converter, an A / D converter, and the like. To. In the input I / F 25, the input unit 30 accepts character input, click, voice input, and the like. The received input contents are stored in the main storage unit 22 or the auxiliary storage unit 24.

å ¥åé¨ï¼ï¼ã¯ãã¿ããããã«ãã­ã¼ãã¼ãããã¦ã¹ããã³ã¿ãã¬ããããã¤ã¯ç­ããæ§æãããæ¸¬å®è£ ç½®ï¼ï¼ã«æå­å ¥ååã¯é³å£°å ¥åãè¡ããå ¥åé¨ï¼ï¼ã¯ãæ¸¬å®è£ ç½®ï¼ï¼ã®å¤é¨ããæ¥ç¶ããã¦ããæ¸¬å®è£ ç½®ï¼ï¼ã¨ä¸ä½ã¨ãªã£ã¦ãã¦ãããã The input unit 30 is composed of a touch panel, a keyboard, a mouse, a pen tablet, a microphone, and the like, and inputs characters or voices to the measuring device 20. The input unit 30 may be connected from the outside of the measuring device 20 or may be integrated with the measuring device 20.

åºåï¼©ï¼ï¼¦ï¼ï¼ã¯ãä¾ãã°å ¥åï¼©ï¼ï¼¦ï¼ï¼ã¨åæ§ã®ã¤ã³ã¿ãã§ã¼ã¹ããæ§æããããåºåï¼©ï¼ï¼¦ï¼ï¼ã¯ãï¼£ï¼°ï¼µï¼ï¼ãçæããæ å ±ãåºåé¨ï¼ï¼ã«åºåãããåºåï¼©ï¼ï¼¦ï¼ï¼ã¯ãï¼£ï¼°ï¼µï¼ï¼ãçæããè£å©è¨æ¶é¨ï¼ï¼ã«è¨æ¶ããæ å ±ããåºåé¨ï¼ï¼ã«åºåããã The output I / F 26 is composed of an interface similar to that of the input I / F 25, for example. The output I / F 26 outputs the information generated by the CPU 21 to the output unit 31. The output I / F 26 outputs the information generated by the CPU 21 and stored in the auxiliary storage unit 24 to the output unit 31.

åºåé¨ï¼ï¼ã¯ãä¾ãã°ãã£ã¹ãã¬ã¤ãããªã³ã¿ã¼ç­ã§æ§æãããæ¸¬å®ã¦ãããï¼ï¼ããéä¿¡ãããæ¸¬å®çµæåã³æ¸¬å®è£ ç½®ï¼ï¼ã«ãããåç¨®æä½ã¦ã¤ã³ãã¦ãæ¸¬å®çµæç­ãè¡¨ç¤ºããã The output unit 31 is composed of, for example, a display, a printer, or the like, and displays measurement results transmitted from the measurement unit 40, various operation windows in the measurement device 20, measurement results, and the like.

ã¡ãã£ã¢ï¼©ï¼ï¼¦ï¼ï¼ã¯ãè¨æ¶åªä½ï¼ï¼ã«è¨æ¶ãããä¾ãã°ã¢ããªã±ã¼ã·ã§ã³ã½ããç­ãèª­ã¿åºããèª­ã¿åºãããã¢ããªã±ã¼ã·ã§ã³ã½ããç­ã¯ãä¸»è¨æ¶é¨ï¼ï¼åã¯è£å©è¨æ¶é¨ï¼ï¼ã«è¨æ¶ããããã¾ããã¡ãã£ã¢ï¼©ï¼ï¼¦ï¼ï¼ã¯ãï¼£ï¼°ï¼µï¼ï¼ãçæããæ å ±ãè¨æ¶åªä½ï¼ï¼ã«æ¸ãè¾¼ããã¡ãã£ã¢ï¼©ï¼ï¼¦ï¼ï¼ã¯ãï¼£ï¼°ï¼µï¼ï¼ãçæããè£å©è¨æ¶é¨ï¼ï¼ã«è¨æ¶ããæ å ±ããè¨æ¶åªä½ï¼ï¼ã«æ¸ãè¾¼ãã The media I / F 27 reads out, for example, application software stored in the storage medium 32. The read application software and the like are stored in the main storage unit 22 or the auxiliary storage unit 24. Further, the media I / F 27 writes the information generated by the CPU 21 to the storage medium 32. The media I / F 27 writes the information generated by the CPU 21 and stored in the auxiliary storage unit 24 to the storage medium 32.

è¨æ¶åªä½ï¼ï¼ã¯ããã¬ã­ã·ãã«ãã£ã¹ã¯ãï¼£ï¼¤ï¼ï¼²ï¼¯ï¼­ãåã¯ï¼¤ï¼¶ï¼¤ï¼ï¼²ï¼¯ï¼­ç­ã§æ§æããããè¨æ¶åªä½ï¼ï¼ã¯ããã¬ã­ã·ãã«ãã£ã¹ã¯ãã©ã¤ããï¼£ï¼¤ï¼ï¼²ï¼¯ï¼­ãã©ã¤ããåã¯ï¼¤ï¼¶ï¼¤ï¼ï¼²ï¼¯ï¼­ãã©ã¤ãç­ã«ãã£ã¦ã¡ãã£ã¢ï¼©ï¼ï¼¦ï¼ï¼ã¨æ¥ç¶ããããè¨æ¶åªä½ï¼ï¼ã«ã¯ãã³ã³ãã¥ã¼ã¿ããªãã¬ã¼ã·ã§ã³ãå®è¡ããããã®ã¢ããªã±ã¼ã·ã§ã³ãã­ã°ã©ã ç­ãæ ¼ç´ããã¦ãã¦ãããã The storage medium 32 is composed of a flexible disk, a CD-ROM, a DVD-ROM, or the like. The storage medium 32 is connected to the media I / F 27 by a flexible disk drive, a CD-ROM drive, a DVD-ROM drive, or the like. The storage medium 32 may store an application program or the like for the computer to execute an operation.

ï¼£ï¼°ï¼µï¼ï¼ã¯ãæ¸¬å®è£ ç½®ï¼ï¼ã®å¶å¾¡ã«å¿ è¦ãªã¢ããªã±ã¼ã·ã§ã³ã½ãããåç¨®è¨­å®ãï¼²ï¼¯ï¼­ï¼ï¼åã¯è£å©è¨æ¶é¨ï¼ï¼ããã®èª­ã¿åºãã«ä»£ãã¦ããããã¯ã¼ã¯ãä»ãã¦åå¾ãã¦ããããåè¨ã¢ããªã±ã¼ã·ã§ã³ãã­ã°ã©ã ããããã¯ã¼ã¯ä¸ã®ãµã¼ãã³ã³ãã¥ã¼ã¿ã®è£å©è¨æ¶é¨ï¼ï¼å ã«æ ¼ç´ããã¦ããããã®ãµã¼ãã³ã³ãã¥ã¼ã¿ã«æ¸¬å®è£ ç½®ï¼ï¼ãã¢ã¯ã»ã¹ãã¦ãã³ã³ãã¥ã¼ã¿ãã­ã°ã©ã ããã¦ã³ã­ã¼ããããããï¼²ï¼¯ï¼­ï¼ï¼åã¯è£å©è¨æ¶é¨ï¼ï¼ã«è¨æ¶ãããã¨ãå¯è½ã§ããã The CPU 21 may acquire the application software and various settings necessary for controlling the measuring device 20 via the network instead of reading from the ROM 23 or the auxiliary storage unit 24. The application program is stored in the auxiliary storage unit 24 of the server computer on the network, and the measuring device 20 accesses the server computer, downloads the computer program, and stores it in the ROM 23 or the auxiliary storage unit 24. It is also possible.

ã¾ããï¼²ï¼¯ï¼­ï¼ï¼åã¯è£å©è¨æ¶é¨ï¼ï¼ã«ã¯ãä¾ãã°ç±³å½ãã¤ã¯ã­ã½ããç¤¾ãè£½é è²©å£²ããï¼·ï½ï½ï½ï½ï½ï½ï¼ç»é²åæ¨ï¼ç­ã®ã°ã©ãã£ã«ã«ã¦ã¼ã¶ã¤ã³ã¿ãã§ã¼ã¹ç°å¢ãæä¾ãããªãã¬ã¼ã·ã§ã³ã·ã¹ãã ãã¤ã³ã¹ãã¼ã«ããã¦ãã¦ããããç¬¬ï¼ã®å®æ½æ æ§ã«ä¿ãã¢ããªã±ã¼ã·ã§ã³ãã­ã°ã©ã ã¯ãåè¨ãªãã¬ã¼ãã£ã³ã°ã·ã¹ãã ä¸ã§åä½ãããã®ã¨ãããããªãã¡ãæ¸¬å®è£ ç½®ï¼ï¼ã¯ããã¼ã½ãã«ã³ã³ãã¥ã¼ã¿ç­ã§ããå¾ããã¾ããæ¸¬å®è£ ç½®ï¼ï¼ã¯ãæ¸¬å®ã¦ãããï¼ï¼ã«å èµããã¦ãã¦ãããã Further, the ROM 23 or the auxiliary storage unit 24 may be equipped with an operation system that provides a graphical user interface environment such as Windows (registered trademark) manufactured and sold by Microsoft Corporation in the United States. The application program according to the fifth embodiment shall operate on the operating system. That is, the measuring device 20 may be a personal computer or the like. Further, the measuring device 20 may be built in the measuring unit 40.

ï¼»ï¼ï¼ï¼ï¼æ å ±åå¾è£ ç½®ã®æ§æï¼½

å³ï¼ã«ãæ å ±åå¾è£ ç½®ï¼ï¼ã®ãã¼ãã¦ã§ã¢ã®æ§æãç¤ºããæ å ±åå¾è£ ç½®ï¼ï¼ã¯ãå ¥åé¨ï¼ï¼ã¨ãåºåé¨ï¼ï¼ã¨ãè¨æ¶åªä½ï¼ï¼ã¨æ¥ç¶ããã¦ãã¦ãããã [3-2. Information acquisition device configuration]

FIG. 1 shows the hardware configuration of the information acquisition device 50. The information acquisition device 50 may be connected to the input unit 60, the output unit 61, and the storage medium 62.

æ å ±åå¾è£ ç½®ï¼ï¼ã«ããã¦ãå¦çé¨ï¼ï¼£ï¼°ï¼µï¼ï¼ï¼ã¨ãä¸»è¨æ¶é¨ï¼ï¼ã¨ãï¼²ï¼¯ï¼­ï¼ï½ï½ ï½ï½ ï½ï½ï½ï½ ï½ï½ ï½ï½ï½ï½ï¼ï¼ï¼ã¨ãè£å©è¨æ¶é¨ï¼ï¼ã¨ãéä¿¡ã¤ã³ã¿ãã§ã¼ã¹ï¼ï¼©ï¼ï¼¦ï¼ï¼ï¼ã¨ãå ¥åã¤ã³ã¿ãã§ã¼ã¹ï¼ï¼©ï¼ï¼¦ï¼ï¼ï¼ã¨ãåºåã¤ã³ã¿ãã§ã¼ã¹ï¼ï¼©ï¼ï¼¦ï¼ï¼ï¼ã¨ãã¡ãã£ã¢ã¤ã³ã¿ã¼ãã§ã¼ã¹ï¼ï¼©ï¼ï¼¦ï¼ï¼ï¼ã¯ããã¹ï¼ï¼ã«ãã£ã¦äºãã«ãã¼ã¿éä¿¡å¯è½ã«æ¥ç¶ããã¦ããã

åæ§æã®è©³ç´°ã¯ãä¸è¨ï¼ï¼ï¼ï¼ã«è¨è¼ã®å¯¾å¿ããåæ§æã®èª¬æãããã«æ´ç¨ããã In the information acquisition device 50, the processing unit (CPU) 51, the main storage unit 52, the ROM (read only memory) 53, the auxiliary storage unit 54, the communication interface (I / F) 58, and the input interface (I /). The F) 55, the output interface (I / F) 56, and the media interface (I / F) 57 are connected to each other by a bus 59 so as to be capable of data communication.

The details of each configuration are described in 3-1. The description of each corresponding configuration described in is incorporated herein by reference.

ï¼»ï¼ï¼ï¼ï¼æ¸¬å®ã¦ãããã®æ§æï¼½

æ¸¬å®ã¦ãããï¼ï¼ã¯ãå°ãªãã¨ãã·ã°ãã«ãæ¤åºããããã®ï¼£ï¼£ï¼¤ã«ã¡ã©ç­ã®æ®åè£ ç½®ãåããæ¤åºé¨ï¼ï¼ãåããå ´åã«ãã£ã¦ã¯ãããã«æ¸¬å®è©¦æãèª¿è£½ããããã®è©¦æèª¿è£½é¨ï¼ï¼ãåãã¦ãã¦ããããã¾ããæ¤åºé¨ï¼ï¼ã¯ããã­ã¼ãµã¤ãã¡ã¼ã¿ã§ãã£ã¦ããããæ¤åºé¨ï¼ï¼ã¯ããã¤ã¯ã­ã¦ã§ã«ã«æ¸¬å®è©¦æä¸­ã®ãã¼ãºãé ç½®ããããã®å å§è£ ç½®ãæ¸å§è£ ç½®ãåã¯é å¿è£ ç½®ãåãã¦ãã¦ãããï¼å³ç¤ºããï¼ã [3-3. Measurement unit configuration]

The measurement unit 40 may include at least a detection unit 10 provided with an image pickup device such as a CCD camera for detecting a signal, and may further include a sample preparation unit 30 for preparing a measurement sample. Further, the detection unit 10 may be a flow cytometer. The detection unit 10 may include a pressurizing device, a depressurizing device, or a centrifuge device for arranging the beads in the measurement sample in the microwell (not shown).

æ¸¬å®ã¦ãããï¼ï¼ã¯ãæ¸¬å®è£ ç½®ï¼ï¼åã¯æ å ±åå¾è£ ç½®ï¼ï¼ã¨ä¸ä½åã¨ãªã£ã¦ãã¦ããããæ¤åºé¨ï¼ï¼ã«æ®åè£ ç½®ãåããæ¸¬å®è£ ç½®ï¼ï¼åã¯æ å ±åå¾è£ ç½®ï¼ï¼ã¨ä¸ä½åã¨ãªã£ãè£ ç½®ã¨ãã¦ã¯ãä¾ãã°ãï¼³ï½ï½ï½ï½ï¼´ï¼­ ï¼¨ï¼¤ï¼ï¼ ï¼¡ï½ï½ï½ï½ï½ï½ ï½ãæãããã¨ãã§ããã The measuring unit 40 may be integrated with the measuring device 20 or the information acquisition device 50. As a device having an image pickup device in the detection unit 10 and integrated with the measurement device 20 or the information acquisition device 50, for example, Simoa TM HD-1 Analyzer can be mentioned.

ï¼»ï¼ï¼ï¼ï¼æ¸¬å®è£ ç½®ãæ å ±åå¾è£ ç½®ã®åä½ï¼½

å³ï¼ãç¨ãã¦ãæ¸¬å®è£ ç½®ï¼ï¼ã®åä½ã«ã¤ãã¦èª¬æãããæ¸¬å®è£ ç½®ï¼ï¼ã¯ãå¾è¿°ããæ¸¬å®ãã­ã°ã©ã ã«ãããã£ã¦ãå¦çé¨ï¼ï¼ã«ããå¶å¾¡ãããã [3-4. Operation of measuring device and information acquisition device]

The operation of the measuring device 20 will be described with reference to FIG. The measuring device 20 is controlled by the processing unit 21 according to a measurement program described later.

åãã«ãå¦çé¨ï¼ï¼ã¯ãæ¤æ»è ãå ¥åé¨ï¼ï¼ããè¡ããåè¨æ¸¬å®è©¦æã«ã¤ãã¦ãåè¨å ç«è¤åä½ã«ç±æ¥ããã·ã°ãã«ãåå¾ããããã®å ¥åãåãä»ããï¼å³ç¤ºããï¼ãæ¬¡ã«æ¸¬å®ã¦ãããï¼ï¼ã§æ¤åºãããåè¨å ç«è¤åä½ã«ç±æ¥ããã·ã°ãã«ãåå¾ããï¼ã¹ãããï¼³ï¼ï¼ãå¦çé¨ï¼ï¼ã¯ããããã®åå¾ããã·ã°ãã«ã®å¼·åº¦ãè£å©è¨æ¶é¨ï¼ï¼ç­ã«è¨æ¶ããã First, the processing unit 21 receives an input (not shown) for acquiring a signal derived from the immune complex for the measurement sample, which is performed by the inspector from the input unit 30. Next, a signal derived from the immune complex detected by the measurement unit 40 is acquired (step S1). The processing unit 21 stores the intensities of these acquired signals in the auxiliary storage unit 54 and the like.

æ¬¡ã«å³ï¼ãç¨ãã¦ãæ å ±åå¾è£ ç½®ï¼ï¼ã®åä½ã«ã¤ãã¦èª¬æãããæ å ±åå¾è£ ç½®ï¼ï¼ã¯ãå¾è¿°ããæ å ±åå¾ãã­ã°ã©ã ã«ãããã£ã¦ãå¦çé¨ï¼ï¼ã«ããå¶å¾¡ãããã Next, the operation of the information acquisition device 50 will be described with reference to FIG. The information acquisition device 50 is controlled by the processing unit 51 according to an information acquisition program described later.

åãã«ãå¦çé¨ï¼ï¼ã¯ãæ¤æ»è ãå ¥åé¨ï¼ï¼ããè¡ããåè¨æ¸¬å®è©¦æã«ã¤ãã¦ãåè¨å ç«è¤åä½ã«ç±æ¥ããã·ã°ãã«ãåå¾ããããã®å ¥åãåãä»ããï¼å³ç¤ºããï¼ãæ¬¡ã«æ¸¬å®ã¦ãããï¼ï¼ã§æ¤åºãããåè¨å ç«è¤åä½ã«ç±æ¥ããã·ã°ãã«ãåå¾ããï¼ã¹ãããï¼³ï¼ï¼ãç¶ãã¦ãè£å©è¨æ¶é¨ï¼ï¼ç­ã«è¨æ¶ããã¦ããã·ã°ãã«å¼·åº¦ã®åºæºå¤ã¨ãåå¾ããã·ã°ãã«å¼·åº¦ãæ¯è¼ããï¼ã¹ãããï¼³ï¼ï¼ãå¦çé¨ï¼ï¼ã¯ãã¹ãããï¼³ï¼ã«ãããæ¯è¼ã«ããã¦ãåè¨æ¸¬å®è©¦æã«ã¤ãã¦åå¾ãããã·ã°ãã«ãåºæºå¤ããé«ãå ´åã«ã¯ï¼ã¹ãããï¼³ï¼ï¼ãè¢«é¨è ãã¢ã«ããã¤ãã¼ç ã®å¯è½æ§ãããã¨æ±ºå®ããï¼ã¹ãããï¼³ï¼ï¼ãã¾ãå¦çé¨ï¼ï¼ã¯ãã¹ãããï¼³ï¼ã«ãããæ¯è¼ã«ããã¦ãåè¨æ¸¬å®è©¦æã«ã¤ãã¦åå¾ãããã·ã°ãã«ãåºæºå¤ããä½ãå ´åã«ã¯ï¼ã¹ãããï¼³ï¼ï¼ãè¢«é¨è ãã¢ã«ããã¤ãã¼ç ã®å¯è½æ§ããªãã¨æ±ºå®ããï¼ã¹ãããï¼³ï¼ï¼ãå¦çé¨ï¼ï¼ã¯ããããã®æ±ºå®çµæãã¢ã«ããã¤ãã¼ç ã§ãããå¦ãã®æ å ±ã¨ãã¦è£å©è¨æ¶é¨ï¼ï¼ç­ã«è¨æ¶ãããå¦çé¨ï¼ï¼ã¯ããããã®çµæãåºåé¨ï¼ï¼ã«åºåãããããããã¯è¨æ¶åªä½ï¼ï¼ã«è¨æ¶ãã¦ãããã First, the processing unit 51 receives an input (not shown) for acquiring a signal derived from the immune complex for the measurement sample, which is performed by the inspector from the input unit 60. Next, a signal derived from the immune complex detected by the measurement unit 40 is acquired (step S1). Subsequently, the reference value of the signal intensity stored in the auxiliary storage unit 54 or the like is compared with the acquired signal intensity (step S2). In the comparison in step S2, the processing unit 51 determines that the subject may have Alzheimer's disease if the signal obtained for the measurement sample is higher than the reference value (step S3). Further, in the comparison in step S2, when the signal acquired for the measurement sample is lower than the reference value (step S3), the processing unit 51 determines that the subject is unlikely to have Alzheimer's disease (step S4). The processing unit 51 stores these determination results in the auxiliary storage unit 54 or the like as information on whether or not the patient has Alzheimer's disease. The processing unit 51 may output these results to the output unit 61 or store them in the storage medium 62.

ï¼»ï¼ï¼ãªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªãæ¸¬å®ããããã®ã³ã³ãã¥ã¼ã¿ãã­ã°ã©ã ãã¢ã«ããã¤ãã¼ç ã§ãããå¦ãã®æ å ±ãåå¾ããããã®ã³ã³ãã¥ã¼ã¿ãã­ã°ã©ã ï¼½

æ¬çºæã®ç¬¬ï¼ã®å®æ½æ æ§ã¯ããªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªãæ¸¬å®ããããã®ã³ã³ãã¥ã¼ã¿ãã­ã°ã©ã ï¼ä»¥ä¸ãæ¸¬å®ãã­ã°ã©ã ã¨ããï¼ã«é¢ãããå ·ä½çã«ã¯ãä¸è¨ï¼ï¼ï¼ã§è¿°ã¹ããæ¸¬å®è£ ç½®ï¼ï¼ã®åä½ãå¶å¾¡ããæ¸¬å®ãã­ã°ã©ã ã§ãããåè¨æ¸¬å®ãã­ã°ã©ã ãã³ã³ãã¥ã¼ã¿ã«å®è¡ãããåã¹ãããã¯ãå³ï¼ã«è¨è¼ã®ã¹ãããï¼³ï¼ã§ãããä¸è¨ï¼ï¼åã³ï¼ï¼ã«è¨è¼ã®åç¨èªã®èª¬æã¯ãããã«æ´ç¨ãããã [4. Computer program for measuring phosphorylated tau protein, computer program for obtaining information on whether or not Alzheimer's disease is present]

A fifth embodiment of the present invention relates to a computer program for measuring phosphorylated tau protein (hereinafter referred to as a measurement program). Specifically, it is a measurement program that controls the operation of the measuring device 20 described in 3-4 above. Each step that the measurement program causes the computer to execute is step S1 shown in FIG. Above 1. And 2. The explanation of each term described in is incorporated herein by reference.

æ¬çºæã®ç¬¬ï¼ã®å®æ½æ æ§ã¯ãã¢ã«ããã¤ãã¼ç ã§ãããå¦ãã®æ å ±ãåå¾ããããã®ã³ã³ãã¥ã¼ã¿ãã­ã°ã©ã ï¼ä»¥ä¸ãæ å ±åå¾ãã­ã°ã©ã ã¨ããï¼ã«é¢ãããå ·ä½çã«ã¯ãä¸è¨ï¼ï¼ï¼ã§è¿°ã¹ããæ å ±åå¾è£ ç½®ï¼ï¼ã®åä½ãå¶å¾¡ããæ¸¬å®ãã­ã°ã©ã ã§ãããåè¨æ å ±åå¾ãã­ã°ã©ã ãã³ã³ãã¥ã¼ã¿ã«å®è¡ãããåã¹ãããã¯ãå³ï¼ã«è¨è¼ã®ã¹ãããï¼³ï¼ããï¼³ï¼ã§ãããä¸è¨ï¼ï¼åã³ï¼ï¼ã«è¨è¼ã®åç¨èªã®èª¬æã¯ãããã«æ´ç¨ãããã A sixth embodiment of the present invention relates to a computer program (hereinafter referred to as an information acquisition program) for acquiring information on whether or not Alzheimer's disease is present. Specifically, it is a measurement program that controls the operation of the information acquisition device 50 described in 3-4 above. Each step that the information acquisition program causes the computer to execute is steps S1 to S5 shown in FIG. Above 1. And 2. The explanation of each term described in is incorporated herein by reference.

ããã«ãç¬¬ï¼åã³ç¬¬ï¼ã®å®æ½æ æ§ã«ä¿ãã³ã³ãã¥ã¼ã¿ãã­ã°ã©ã ã¯ããã¼ããã£ã¹ã¯ããã©ãã·ã¥ã¡ã¢ãªç­ã®åå°ä½ã¡ã¢ãªç´ å­ãå ãã£ã¹ã¯ç­ã®è¨æ¶åªä½ã«è¨æ¶ããã¦ãã¦ããããåè¨è¨æ¶åªä½ã¸ã®ãã­ã°ã©ã ã®è¨æ¶å½¢å¼ã¯ãåè¨æ å ±åå¾è£ ç½®ãåè¨ãã­ã°ã©ã ãèª­ã¿åãå¯è½ã§ããéãå¶éãããªããåè¨è¨æ¶åªä½ã¸ã®è¨æ¶ã¯ãä¸æ®çºæ§ã§ãããã¨ãå¥½ã¾ããã Further, the computer program according to the fifth and sixth embodiments may be stored in a semiconductor memory element such as a hard disk or a flash memory, or a storage medium such as an optical disk. The storage format of the program in the storage medium is not limited as long as the information acquisition device can read the program. The storage in the storage medium is preferably non-volatile.

ï¼»ï¼ï¼ãªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªã®æ¤åºç¨è©¦è¬åã³è©¦è¬ã­ããï¼½

æ¬çºæã®ç¬¬ï¼ã®å®æ½æ æ§ã¯ããªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªãæ¤åºããããã®è©¦è¬ã«é¢ãããå³ï¼ã«ãæ¬å®æ½æ æ§ã®è©¦è¬ãåå®¹ããå®¹å¨ï¼ï¼ï¼ã®æ¦ç¥å³ãç¤ºããå®¹å¨ï¼ï¼ï¼ã¯ãæ°´ãç·©è¡æ¶²ï¼ä¾ãã°ï¼°ï¼¢ï¼³ï¼ãªã©ã®æ¶²ä½ã¨ãææãã¼ãºã¨ãéææãã¼ãºã¨ãå«ãè©¦è¬ãåå®¹ããã¦ãããè©¦è¬ã«å«æãããææãã¼ãºã¨éææãã¼ãºã®åæ°æ¯ã¯ãä¸è¨ï¼ï¼ï¼ï¼ã§è¿°ã¹ãã¨ããã§ããã

ç¬¬ï¼ã®å®æ½æ æ§ã¯ããªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªãæ¤åºããããã®è©¦è¬ã­ããã«é¢ãããå³ï¼åã³å³ï¼ã«ãæ¬å®æ½æ æ§ã®è©¦è¬ã­ããï¼ï¼ï¼åã³è©¦è¬ã­ããï¼ï¼ï¼ã®æ¦ç¥å³ãç¤ºãã

ç¬¬ï¼ã®å®æ½æ æ§ã®ä¸ä¾ã§ããè©¦è¬ã­ããï¼ï¼ï¼ã¯ãå®¹å¨ï¼ï¼ï¼ã¨ãªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªæ¤åºç¨è©¦è¬ï¼çºå åºè³ªç­ï¼ãåå®¹ããå®¹å¨ï¼ï¼ï¼ãå«ãããã®è©¦è¬ã­ããï¼ï¼ï¼ã¯ãæ¤åºæä½ãå«æããè©¦è¬ãåå®¹ããå®¹å¨ï¼ï¼ï¼ãããã«å«ãã§ãã¦ããããè©¦è¬ã­ããï¼ï¼ï¼ã¯ããã¼ãºã«æææä½ãåºå®åããã¦ããªãå ´åã¯ãæææä½ãå«æããè©¦è¬ï¼å³ç¤ºããï¼ãããã«å«ãã§ãã¦ããããè©¦è¬ã­ããï¼ï¼ï¼ã«ã¯åæ±èª¬ææ¸ãããã¯åãæ±ãèª¬ææ¸ãé²è¦§ã§ããï¼µï¼²ï¼¬ãè¨è¼ããç¨ç´ï¼ï¼ï¼ãå«ã¾ãã¦ããããããã«ãè©¦è¬ã­ããï¼ï¼ï¼ã«ã¯ããããã®å®¹å¨ãç´ããç®±ï¼ï¼ï¼ãå«ã¾ãã¦ãã¦ãããã

ç¬¬ï¼ã®å®æ½æ æ§ã®å¥ã®ä¾ã§ããè©¦è¬ã­ããï¼ï¼ï¼ã¯ãææãã¼ãºã¨éææãã¼ãºã¨ãå¥ã ã®å®¹å¨ï¼ï¼ï¼ï½åã³ï¼ï¼ï¼ï½ã«åå®¹ããããææãã¼ãºã¨éææãã¼ãºã®åæ°æ¯ã¯ä¸ã§è¿°ã¹ãã¨ããã§ããããã®è©¦è¬ã­ããï¼ï¼ï¼ã¯ãããã«ãªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªæ¤åºç¨è©¦è¬ï¼çºå åºè³ªç­ï¼ãåå®¹ããå®¹å¨ï¼ï¼ï¼ãæ¤åºæä½ãå«æããè©¦è¬ãåå®¹ããå®¹å¨ï¼ï¼ï¼ãããã«å«ãã§ãã¦ããããè©¦è¬ã­ããï¼ï¼ï¼ã¯ããã¼ãºã«æææä½ãåºå®åããã¦ããªãå ´åã¯ãæææä½ãå«æããè©¦è¬ï¼å³ç¤ºããï¼ãããã«å«ãã§ãã¦ããããè©¦è¬ã­ããï¼ï¼ï¼ã«ã¯åæ±èª¬ææ¸ãããã¯åãæ±ãèª¬ææ¸ãé²è¦§ã§ããï¼µï¼²ï¼¬ãè¨è¼ããç¨ç´ï¼ï¼ï¼ãå«ã¾ãã¦ããããããã«ãè©¦è¬ã­ããï¼ï¼ï¼ã«ã¯ããããã®å®¹å¨ãç´ããç®±ï¼ï¼ï¼ãå«ã¾ãã¦ãã¦ãããã [5. Reagents and reagent kits for detecting phosphorylated tau protein]

A seventh embodiment of the present invention relates to a reagent for detecting phosphorylated tau protein. FIG. 3 shows a schematic view of a container 151 containing the reagent of this embodiment. The container 151 contains a reagent containing a liquid such as water or a buffer solution (for example, PBS), trapped beads, and non-captured beads. The number ratio of captured beads to non-captured beads contained in the reagent is as described in 1-2. As mentioned in.

Eighth embodiment relates to a reagent kit for detecting phosphorylated tau protein. 4 and 5 show schematic views of the reagent kit 150 and the reagent kit 160 of this embodiment.

The reagent kit 150, which is an example of the eighth embodiment, includes a container 151 and a container 152 containing a reagent for detecting phosphorylated tau protein (such as a luminescent substrate). The reagent kit 150 may further include a container 153 containing a reagent containing the detection antibody. If the capture antibody is not immobilized on the beads, the reagent kit 150 may further contain a reagent (not shown) containing the capture antibody. The reagent kit 150 may include an instruction manual or a paper 154 on which a URL for viewing the instruction manual is described. Further, the reagent kit 150 may include a box 155 containing these containers.

In another example of the eighth embodiment, the reagent kit 160 contains captured beads and non-captured beads in separate containers 161a and 161b. The number ratio of captured beads to non-captured beads is as described above. The reagent kit 160 may further include a container 162 containing a reagent for detecting phosphorylated tau protein (such as a luminescent substrate) and a container 163 containing a reagent containing a detection antibody. If the capture antibody is not immobilized on the beads, the reagent kit 160 may further contain a reagent (not shown) containing the capture antibody. The reagent kit 160 may include an instruction manual or a paper 164 containing a URL for viewing the instruction manual. Further, the reagent kit 160 may include a box 165 containing these containers.

ä»¥ä¸ãæ¬çºæã®åå®æ½æ æ§ããæ·»ä»ã®å³é¢ãåç §ãã¦è©³ç´°ã«èª¬æããããæ¬çºæã«ãããçä½è©¦æä¸­ã®ãªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªãæ¸¬å®ããæ¹æ³ãã¢ã«ããã¤ãã¼ç ã«ç½¹æ£ãã¦ãããå¦ãã®æ å ±ãåå¾ããæ¹æ³ãçä½è©¦æä¸­ã®ãªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªãæ¸¬å®ããè£ ç½®ãã¢ã«ããã¤ãã¼ç ã«ç½¹æ£ãã¦ãããå¦ãã®æ å ±ãåå¾ããè£ ç½®ãçä½è©¦æä¸­ã®ãªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªãæ¸¬å®ããã³ã³ãã¥ã¼ã¿ãã­ã°ã©ã ãåã³ã¢ã«ããã¤ãã¼ç ã«ç½¹æ£ãã¦ãããå¦ãã®æ å ±ãåå¾ããã³ã³ãã¥ã¼ã¿ãã­ã°ã©ã ã¯ãä¸è¨ã«èª¬æããå ·ä½çãªå®æ½æ æ§ã«éå®ããããã®ã§ã¯ãªããæ¬çºæã®å®æ½æ æ§ã¯ãæ¬æç´°æ¸ã®è¨è¼ã¨å½æ¥­è ã®æè¡å¸¸è­ã«åºã¥ãã¦å¤å½¢ãããã Each embodiment of the present invention has been described in detail with reference to the attached drawings, but the method for measuring phosphorylated tau protein in a biological sample in the present invention, information on whether or not the patient has Alzheimer's disease. A device for measuring phosphorylated tau protein in a biological sample, a device for acquiring information on whether or not the patient has Alzheimer's disease, a computer program for measuring phosphorylated tau protein in a biological sample, and Alzheimer's disease. The computer program that obtains information on whether or not the patient has the disease is not limited to the specific embodiment described above. Embodiments of the present invention may be modified based on the description of the present specification and the common general knowledge of those skilled in the art.

ä»¥ä¸ã«å®æ½ä¾ãç¤ºãã¦ãæ¬çºæãããè©³ç´°ã«èª¬æããããæ¬çºæã¯å®æ½ä¾ã«éå®ãã¦è§£éããããã®ã§ã¯ãªãã Hereinafter, the present invention will be described in more detail with reference to Examples, but the present invention is not construed as being limited to Examples.

ï¼ï¼ELISAæ³ã«ãããªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªã®æ¤åº

ï¼ï¼ï¼ææãã¼ãºåã³ããªãã³æ¨è­æä½ã®èª¿è£½

æ¨çã¿ã³ãã¯è³ªãææããããã®æä½ï¼è£è¶³æä½ï¼ãçµåãããææãã¼ãºãåã³æ¨çã¿ã³ãã¯è³ªãæ¤åºããããã®ããªãã³æ¨è­æä½ï¼æ¤åºæä½ï¼ã¯ãSimoaTM Homebrew Assay Development kitï¼Quanterixç¤¾ï¼ãç¨ãã¦ãã­ããæ·»ä»ã®ãã­ãã³ã¼ã«ã«ãããã£ã¦èª¿è£½ãããã¾ããåè¨èª¿è£½ã«ã¯ãã­ããã«æ·»ä»ã®1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride ï¼EDCï¼Thermo Fisher Scientificï¼ãããªãã³ï¼Thermo Fisher Scientificï¼ãé å¿æ¿¾éãã£ã«ã¿ã¼ï¼Merck Milliporeï¼ãä½¿ç¨ããã 1. 1. Detection of phosphorylated tau protein by ELISA method (1) Preparation of capture beads and biotin-labeled antibody Capture beads to which an antibody (supplementary antibody) for capturing the target protein (supplementary antibody) is bound, and biotin-labeled antibody for detecting the target protein (Detected antibody) was prepared using the Simoa TM Homebrew Assay Development kit (Quanterix) according to the protocol attached to the kit. In addition, 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (EDC: Thermo Fisher Scientific), biotin (Thermo Fisher Scientific), and a centrifugal filtration filter (Merck Millipore) attached to the kit were used for the preparation.

æä½ã¯ãã¿ã¦ã¿ã³ãã¯è³ªã®aa.159-163ãèªè­ããæä½(Anti-Human Tau Monoclonal Antibody, Purified, clone:HT7; Thermo SCIENTIFIC)ãåã³ãªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªã®Thr181ã®ãªã³é ¸åãèªè­ããæä½ï¼Anti-Human PHF-Tau Monoclonal Antibody, Purified, clone:AT270, Thermo SCIENTIFICï¼ãä½¿ç¨ãããä»¥ä¸åè ãHT7æä½ãå¾è ãAT270æä½ã¨ããã Antibodies are antibodies that recognize the aa.159-163 tau protein (Anti-Human Tau Monoclonal Antibody, Purified, clone: HT7; Thermo SCIENTIFIC) and antibodies that recognize the phosphorylation of the phosphorylated tau protein Thr181 (Anti-). Human PHF-Tau Monoclonal Antibody, Purified, clone: AT270, Thermo SCIENTIFIC) was used. Hereinafter, the former is referred to as HT7 antibody and the latter is referred to as AT270 antibody.

ï¼ï¼ï¼ã¤ã ãã¢ãã»ã¤

ä¸è¨ï¼ï¼ï¼ã§èª¿è£½ããææãã¼ãºãåã³ããªãã³æ¨è­æä½ã¨ãQuanterixç¤¾ã®Dye-Encoded Helper Beadsï¼éææãã¼ãºï¼ãSimoaTM Enzyme and Substrate kitãSimoaTM Disk kitãSimoaTM Sealing OilãSystem buffer 1ãSystem buffer 2ãSimoaTM HD-1 Analyzerãä½¿ç¨ããã¡ã¼ã«ã¼ã®ãã­ãã³ã¼ã«ã«ãããã£ã¦ãæ¸¬å®ãè¡ã£ããæ¸¬å®ã¯ãæ¸¬å®ç¨ãµã³ãã«ã¨ãææãã¼ãºãããªãã³æ¨è­æä½ãéææãã¼ãºç­ã®å¿ è¦ãªè©¦è¬ãSimoaTM HD-1 Analyzerã«ã»ããããSimoaTM HD-1 Analyzerã§å ¨ã¦ã®æ¸¬å®å·¥ç¨ãè¡ã£ãã (2) Immunoassay The captured beads and biotin-labeled antibody prepared in (1) above, Dye-Encoded Helper Beads (non-captured beads) from Quanterix, Simoa TM Enzyme and Substrate kit, Simoa TM Disk kit, Simoa TM Sealing Oil. , System buffer 1, System buffer 2, Simoa TM HD-1 Analyzer was used, and the measurement was performed according to the manufacturer's protocol. For the measurement, the measurement sample and necessary reagents such as capture beads, biotin-labeled antibody, and non-capture beads were set in the Simoa TM HD-1 Analyzer, and all the measurement steps were performed with the Simoa TM HD-1 Analyzer.

å ·ä½çãªå·¥ç¨ã¯ä»¥ä¸ã®éãã§ãããåãã«ãéææãã¼ãºã®å­å¨ä¸ã§ãææãã¼ãºã«çµåããã¦ããæææä½ã¨æ¨çã¿ã³ãã¯è³ªã¨ãçµåããããç¶ãã¦ããªãã³åãããæ¤åºæä½ããè£è¶³æä½ã¨çµåããæ¨çã¿ã³ãã¯è³ªã«ããã«çµåãããææãã¼ãºä¸ã«è£è¶³æä½ã¨æ¨çã¿ã³ãã¯è³ªã¨ããªãã³åæ¤åºæä½ã®å ç«è¤åä½ãå½¢æããããåè¨å·¥ç¨å¾ãéææãã¼ãºã®å­å¨ä¸ã§ææãã¼ãºã¨Î²ã¬ã©ã¯ãã·ãã¼ã¼ãçµåãããã¹ãã¬ããã¢ãã¸ã³ã¨ãåå¿ããããåè¨å·¥ç¨å¾ãéææãã¼ãºã®å­å¨ä¸ã§ææãã¼ãºãÎ²ã¬ã©ã¯ãã·ãã¼ã¼ã®åºè³ªï¼RGP: ã¬ã½ã«ãã£ã³Î²-D-ã¬ã©ã¯ããã©ãã·ãï¼ã¨åå¿ããããRGPã¨ã®åå¿ãçµãã£ãææãã¼ãºã¨éææãã¼ãºããSimoaTM Diskã«ã¢ãã©ã¤ããããã®å¾ãã¢ãã©ã¤ããããã¼ãºã¯ãå¤æ°ã®ãã§ã ããªããã«åä½ã®ã¦ã§ã«ãé ç½®ãããã¢ã¬ã¤ã®åã¦ã§ã«ã«ä¸ã¤ãã¤æ ¼ç´ããããã¦ã§ã«ã«æ ¼ç´ãããåãã¼ãºãSimoaTM HD-1 Analyzerãæ®å½±ããèå å¼·åº¦ï¼AEBï¼ãæ¸¬å®ãèå å¼·åº¦ã®å¼·ããã¼ãºã®æ°ãæ¸¬å®ãããã¨ã«ãããæ¨çã¿ã³ãã¯è³ªãå®éããã The specific process is as follows. First, in the presence of non-capture beads, the capture antibody bound to the capture beads was bound to the target protein. Subsequently, the biotinylated detection antibody was further bound to the target protein bound to the supplementary antibody, and an immune complex of the supplementary antibody, the target protein and the biotinylated detection antibody was formed on the capture beads. After the above step, the captured beads were reacted with Î²-galactosidase-bound streptavidin in the presence of non-captured beads. After the above step, the captured beads were reacted with a substrate of Î²-galactosidase (RGP: resorphin Î²-D-galactopyranoside) in the presence of non-captured beads. Captured and non-captured beads that had reacted with RGP were applied to Simoa TM Disk. The applied beads were then stored one in each well of the array in which a large number of femtolitre wells were arranged. Each bead stored in the well was photographed by Simoa TM HD-1 Analyzer, the fluorescence intensity (AEB) was measured, and the number of beads with strong fluorescence intensity was measured to quantify the target protein.

ï¼ï¼å®æ½ä¾ï¼

æææä½ã¨ãã¦HT7æä½ãä½¿ç¨ããæ¤åºæä½ã¨ãã¦AT270æä½ãä½¿ç¨ãã¦ãææãã¼ãºã¨éææãã¼ãºã®æé©æ¯ãæ¤è¨ãããå®é¨ã¯ä¸è¨ï¼ï¼ã«è¨è¼ã®æ¹æ³ã«æºãããæ¤è¨ã«ã¯ããªã³é ¸åã¿ã¦ã¿ã³ãã¯è³ªã§ããHuman Tau [pT181] phosphoELISATMELISA kit (Thermo FisherScientific)ã«æ·»ä»ã®Hu Tau [pT181] Standardã0.039 pg/mlã¨ãªãããã«SimoaTM Homebrew Assay Development kitã«æ·»ä»ã®Sample Diluentã§å¸éãããã®ãæ¸¬å®ç¨ãµã³ãã«ã¨ãã¦ä½¿ç¨ããã1åã®æ¸¬å®ã«ã¯ã0.039 pg/ml Hu Tau [pT181] Standardã152Î¼lä½¿ç¨ããã 2. 2. Example 1

Using the HT7 antibody as the capture antibody and the AT270 antibody as the detection antibody, the optimum ratio of capture beads to non-capture beads was investigated. The experiment is described in 1. above. According to the method described in. For the study, the Hu Tau [pT181] Standard attached to the phosphorylated tau protein Human Tau [pT181] phosphoELISA TM ELISA kit (Thermo Fisher Scientific) was attached to the Simoa TM Homebrew Assay Development kit so that it was 0.039 pg / ml. The sample diluted with Sample Diluent was used as a measurement sample. For one measurement, 152 Î¼l of 0.039 pg / ml Hu Tau [pT181] Standard was used.

ææãã¼ãºã¨éææãã¼ãºã®åè¨ã100ï¼ ã¨ããéææãã¼ãºã®å²åã10ã20ã30ã40ã50ã60ã70ã80ãåã³90ï¼ ã¨å¤åããã¦ã0.039 pg/mlã®pT181ãæ¸¬å®ããéã®ãAEBãæ¯è¼ãããçµæãå³ï¼ã«ç¤ºããçµæã¨ãã¦ãéææãã¼ãºã60ï¼ ä»¥ä¸ã®æã«å¼·ãAEBãå¾ãããã The total of captured and non-captured beads is 100%, and the proportion of non-captured beads is changed to 10, 20, 30, 40, 50, 60, 70, 80, and 90% to obtain 0.039 pg / ml pT181. The AEBs at the time of measurement were compared. The results are shown in FIG. As a result, strong AEB was obtained when the non-captured beads were 60% or more.

ãã®ãã¨ãã